Gene ID	Gene Symbol	Label IDs	Label Names
PA267	ABCB1	PA166123409;PA166159586	Annotation of EMA Label for aliskiren and ABCB1;Annotation of HCSC Label for aliskiren and ABCB1
PA374	ABCB11	PA166269742;PA166268902	Annotation of EMA Label for odevixibat and ABCB11;Annotation of FDA Label for odevixibat and ABCB11
PA390	ABCG2	PA166184427;PA166184499	Annotation of Swissmedic Label for ezetimibe / rosuvastatin and ABCG2, SLCO1B1;Annotation of Swissmedic Label for rosuvastatin and ABCG2, SLCO1B1
PA36144	ABI1	PA166127660;PA166127682;PA166127693;PA166129527	Annotation of HCSC Label for dasatinib and ABI1, BCR;Annotation of HCSC Label for imatinib and ABI1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB;Annotation of HCSC Label for nilotinib and ABI1, BCR;Annotation of HCSC Label for ponatinib and ABI1, BCR
PA24413	ABL1	PA166117941;PA166104914;PA166104926;PA166105334;PA166122067;PA166268861;PA166159963;PA166114907;PA166104795;PA166104781;PA166114930;PA166104790;PA166177512;PA166104842;PA166114931;PA166182755;PA166273981;PA166127641;PA166123537;PA166123542	Annotation of EMA Label for bosutinib and ABL1, BCR;Annotation of EMA Label for dasatinib and ABL1, BCR;Annotation of EMA Label for imatinib and ABL1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB;Annotation of EMA Label for nilotinib and ABL1, BCR;Annotation of EMA Label for ponatinib and ABL1, BCR;Annotation of FDA Label for asciminib and ABL1, BCR;Annotation of FDA Label for blinatumomab and ABL1, BCR, CD19;Annotation of FDA Label for bosutinib and ABL1, BCR;Annotation of FDA Label for busulfan and ABL1, BCR;Annotation of FDA Label for dasatinib and ABL1, BCR;Annotation of FDA Label for homoharringtonine and ABL1, BCR;Annotation of FDA Label for imatinib and ABL1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB;Annotation of FDA Label for inotuzumab ozogamicin and ABL1, BCR;Annotation of FDA Label for nilotinib and ABL1, BCR;Annotation of FDA Label for ponatinib and ABL1, BCR;Annotation of FDA Label for vincristine and ABL1, BCR;Annotation of HCSC Label for asciminib and ABL1, BCR;Annotation of HCSC Label for bosutinib and ABL1, BCR;Annotation of PMDA Label for dasatinib and ABL1, BCR;Annotation of PMDA Label for imatinib and ABL1, BCR
PA39	ADRB2	PA166104779	Annotation of EMA Label for indacaterol and ADRB2
PA24622	AGPAT2	PA166273381	Annotation of EMA Label for metreleptin and AGPAT2, BSCL2, LEP, LMNB2
PA24633	AGXT	PA166273441;PA166235361;PA166283221	Annotation of EMA Label for lumasiran and AGXT;Annotation of FDA Label for lumasiran and AGXT;Annotation of HCSC Label for lumasiran and AGXT
PA24681	AKR1D1	PA166182940;PA166160056	Annotation of EMA Label for cholic acid and AKR1D1, HSD3B7;Annotation of FDA Label for cholic acid and AKR1D1, AMACR, CYP27A1, CYP7A1, DHCR7, HSD3B2
PA24702	ALDH5A1	PA166272841;PA166236001;PA166278561	Annotation of EMA Label for sodium oxybate and ALDH5A1;Annotation of FDA Label for sodium oxybate and ALDH5A1;Annotation of HCSC Label for sodium oxybate and ALDH5A1
PA24719	ALK	PA166182924;PA166182931;PA166278421;PA166129449;PA166104909;PA166273521;PA166183184;PA166273301;PA166183249;PA166160051;PA166163429;PA166104778;PA166169878;PA166251421;PA166124617;PA166104859;PA166169884;PA166191581;PA166182744;PA166191561;PA166160009;PA166296341;PA166184560;PA166252901;PA166293341;PA166286181;PA166229941;PA166278442;PA166129526;PA166127655;PA166283821;PA166284721;PA166284642;PA166123536	Annotation of EMA Label for alectinib and ALK;Annotation of EMA Label for brigatinib and ALK;Annotation of EMA Label for cemiplimab-rwlc and ALK, CD274, EGFR, ROS1;Annotation of EMA Label for ceritinib and ALK;Annotation of EMA Label for crizotinib and ALK, ROS1;Annotation of EMA Label for ipilimumab and ALK, CD274, EGFR;Annotation of EMA Label for lorlatinib and ALK;Annotation of EMA Label for nivolumab and ALK, CD274, EGFR, ERBB2;Annotation of EMA Label for pembrolizumab and ALK, CD274, EGFR, ERBB2;Annotation of FDA Label for alectinib and ALK;Annotation of FDA Label for atezolizumab and ALK, BRAF, CD274, EGFR;Annotation of FDA Label for brentuximab vedotin and ALK;Annotation of FDA Label for brigatinib and ALK;Annotation of FDA Label for cemiplimab-rwlc and ALK, CD274, EGFR, ROS1;Annotation of FDA Label for ceritinib and ALK;Annotation of FDA Label for crizotinib and ALK, ROS1;Annotation of FDA Label for durvalumab and ALK, CD274, EGFR, PDCD1;Annotation of FDA Label for ipilimumab and ALK, CD274, EGFR;Annotation of FDA Label for lorlatinib and ALK;Annotation of FDA Label for nivolumab and ALK, CD274, EGFR;Annotation of FDA Label for pembrolizumab and ALK, CD274, EGFR, ERBB2;Annotation of FDA Label for pemetrexed and ALK, EGFR;Annotation of FDA Label for ramucirumab and ALK, EGFR;Annotation of FDA Label for tepotinib and ALK, EGFR;Annotation of FDA Label for tremelimumab and ALK, EGFR;Annotation of HCSC Label for alectinib and ALK;Annotation of HCSC Label for atezolizumab and ALK, CD274, EGFR;Annotation of HCSC Label for cemiplimab-rwlc and ALK, CD274, EGFR, ROS1;Annotation of HCSC Label for ceritinib and ALK;Annotation of HCSC Label for crizotinib and ALK;Annotation of HCSC Label for ipilimumab and ALK, CD274, EGFR;Annotation of HCSC Label for nivolumab and ALK, CD274, EGFR, ERBB2;Annotation of HCSC Label for pembrolizumab and ALK, CD274, EGFR, ERBB2;Annotation of PMDA Label for crizotinib and ALK
PA24757	AMACR	PA166160056	Annotation of FDA Label for cholic acid and AKR1D1, AMACR, CYP27A1, CYP7A1, DHCR7, HSD3B2
PA24796	ANGPTL3	PA166283981	Annotation of EMA Label for evinacumab and ANGPTL3, LDLR
PA50	APOB	PA166273581;PA166121250;PA166273561;PA166114923;PA166283901	Annotation of EMA Label for inclisiran and APOB, LDLR, PCSK9;Annotation of EMA Label for lomitapide and APOB, LDLR, PCSK9;Annotation of FDA Label for inclisiran and APOB, LDLR, PCSK9;Annotation of FDA Label for lomitapide and APOB, LDLR, PCSK9;Annotation of HCSC Label for inclisiran and APOB, LDLR, PCSK9
PA55	APOE	PA166104866	Annotation of FDA Label for pravastatin and APOE
PA24922	AQP4	PA166273541;PA166272761;PA166224221;PA166224961;PA166236241;PA166278621	Annotation of EMA Label for inebilizumab-cdon and AQP4;Annotation of EMA Label for satralizumab and AQP4;Annotation of FDA Label for eculizumab and AQP4, CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE;Annotation of FDA Label for inebilizumab-cdon and AQP4;Annotation of FDA Label for satralizumab and AQP4, IL6R;Annotation of HCSC Label for satralizumab and AQP4
PA24947	ARG1	PA166269701;PA166104794;PA166283881	Annotation of EMA Label for glycerol phenylbutyrate and ARG1, ASL, ASS1, CPS1, OTC;Annotation of FDA Label for sodium benzoate / sodium phenylacetate and ARG1, ASL, ASS1, CPS1, NAGS, OTC;Annotation of HCSC Label for glycerol phenylbutyrate and ARG1, ASL, ASS1, CPS1, OTC
PA25046	ASL	PA166269701;PA166104794;PA166283881	Annotation of EMA Label for glycerol phenylbutyrate and ARG1, ASL, ASS1, CPS1, OTC;Annotation of FDA Label for sodium benzoate / sodium phenylacetate and ARG1, ASL, ASS1, CPS1, NAGS, OTC;Annotation of HCSC Label for glycerol phenylbutyrate and ARG1, ASL, ASS1, CPS1, OTC
PA162376926	ASS1	PA166269701;PA166114381;PA166269101;PA166104794;PA166114317;PA166283881;PA166127712	Annotation of EMA Label for glycerol phenylbutyrate and ARG1, ASL, ASS1, CPS1, OTC;Annotation of EMA Label for sodium phenylbutyrate and ASS1, CPS1, OTC;Annotation of FDA Label for glycerol phenylbutyrate and ASS1, CPS1, OTC;Annotation of FDA Label for sodium benzoate / sodium phenylacetate and ARG1, ASL, ASS1, CPS1, NAGS, OTC;Annotation of FDA Label for sodium phenylbutyrate and ASS1, CPS1, OTC;Annotation of HCSC Label for glycerol phenylbutyrate and ARG1, ASL, ASS1, CPS1, OTC;Annotation of HCSC Label for sodium phenylbutyrate and ASS1, CPS1, OTC
PA25294	BCHE	PA166185156;PA166184637;PA166122970;PA166283201;PA166127713;PA166183881	Annotation of FDA Label for mivacurium and BCHE;Annotation of FDA Label for oxymetazoline and tetracaine and BCHE, CYB5R3, G6PD;Annotation of FDA Label for succinylcholine and BCHE, CACNA1S, RYR1;Annotation of HCSC Label for mivacurium and BCHE;Annotation of HCSC Label for succinylcholine and BCHE;Annotation of Swissmedic Label for mivacurium and BCHE
PA25321	BCR	PA166117941;PA166104914;PA166104926;PA166105334;PA166122067;PA166268861;PA166159963;PA166114907;PA166104795;PA166104781;PA166114930;PA166104790;PA166177512;PA166104842;PA166114931;PA166182755;PA166273981;PA166127641;PA166127660;PA166127682;PA166127693;PA166129527;PA166123537;PA166123542	Annotation of EMA Label for bosutinib and ABL1, BCR;Annotation of EMA Label for dasatinib and ABL1, BCR;Annotation of EMA Label for imatinib and ABL1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB;Annotation of EMA Label for nilotinib and ABL1, BCR;Annotation of EMA Label for ponatinib and ABL1, BCR;Annotation of FDA Label for asciminib and ABL1, BCR;Annotation of FDA Label for blinatumomab and ABL1, BCR, CD19;Annotation of FDA Label for bosutinib and ABL1, BCR;Annotation of FDA Label for busulfan and ABL1, BCR;Annotation of FDA Label for dasatinib and ABL1, BCR;Annotation of FDA Label for homoharringtonine and ABL1, BCR;Annotation of FDA Label for imatinib and ABL1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB;Annotation of FDA Label for inotuzumab ozogamicin and ABL1, BCR;Annotation of FDA Label for nilotinib and ABL1, BCR;Annotation of FDA Label for ponatinib and ABL1, BCR;Annotation of FDA Label for vincristine and ABL1, BCR;Annotation of HCSC Label for asciminib and ABL1, BCR;Annotation of HCSC Label for bosutinib and ABL1, BCR;Annotation of HCSC Label for dasatinib and ABI1, BCR;Annotation of HCSC Label for imatinib and ABI1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB;Annotation of HCSC Label for nilotinib and ABI1, BCR;Annotation of HCSC Label for ponatinib and ABI1, BCR;Annotation of PMDA Label for dasatinib and ABL1, BCR;Annotation of PMDA Label for imatinib and ABL1, BCR
PA25374	BLVRB	PA166104823;PA166160718	Annotation of EMA Label for methylene blue and BLVRB, CYB5R3, G6PD;Annotation of PMDA Label for methylene blue and BLVRB, G6PD
PA25408	BRAF	PA166182928;PA166182941;PA166119826;PA166182948;PA166273302;PA166284681;PA166129450;PA166114482;PA166163429;PA166179870;PA166160046;PA166114912;PA166179878;PA166278121;PA166160121;PA166170932;PA166115365;PA166104858;PA166127656;PA166284542;PA166284741;PA166284661;PA166127722;PA166127728;PA166160851	Annotation of EMA Label for binimetinib and BRAF;Annotation of EMA Label for cobimetinib and BRAF;Annotation of EMA Label for dabrafenib and BRAF;Annotation of EMA Label for encorafenib and BRAF;Annotation of EMA Label for nivolumab and BRAF;Annotation of EMA Label for pembrolizumab and BRAF;Annotation of EMA Label for trametinib and BRAF;Annotation of EMA Label for vemurafenib and BRAF;Annotation of FDA Label for atezolizumab and ALK, BRAF, CD274, EGFR;Annotation of FDA Label for binimetinib and BRAF;Annotation of FDA Label for cobimetinib and BRAF;Annotation of FDA Label for dabrafenib and BRAF;Annotation of FDA Label for encorafenib and BRAF;Annotation of FDA Label for nivolumab / relatlimab and BRAF, CD274, LAG3;Annotation of FDA Label for nivolumab and BRAF, ERBB2;Annotation of FDA Label for pembrolizumab and BRAF;Annotation of FDA Label for trametinib and BRAF;Annotation of FDA Label for vemurafenib and BRAF;Annotation of HCSC Label for dabrafenib and BRAF;Annotation of HCSC Label for encorafenib and BRAF;Annotation of HCSC Label for nivolumab and BRAF;Annotation of HCSC Label for pembrolizumab and BRAF;Annotation of HCSC Label for trametinib and BRAF;Annotation of HCSC Label for vemurafenib and BRAF;Annotation of PMDA Label for vemurafenib and BRAF
PA25411	BRCA1	PA166273321;PA166183243;PA166183423;PA166183425;PA166169920;PA166159964;PA166163419;PA166182742;PA166283161;PA166282882	Annotation of EMA Label for niraparib and BRCA1, BRCA2;Annotation of EMA Label for olaparib and BRCA1, BRCA2, ERBB2;Annotation of EMA Label for rucaparib and BRCA1, BRCA2;Annotation of EMA Label for talazoparib and BRCA1, BRCA2, ERBB2;Annotation of FDA Label for niraparib and BRCA1, BRCA2;Annotation of FDA Label for olaparib and BRCA1, BRCA2, ERBB2;Annotation of FDA Label for rucaparib and BRCA1, BRCA2;Annotation of FDA Label for talazoparib and BRCA1, BRCA2;Annotation of HCSC Label for niraparib and BRCA1, BRCA2;Annotation of HCSC Label for olaparib and BRCA1, BRCA2, ERBB2
PA25412	BRCA2	PA166273321;PA166183243;PA166183423;PA166183425;PA166169920;PA166159964;PA166163419;PA166182742;PA166283161;PA166282882	Annotation of EMA Label for niraparib and BRCA1, BRCA2;Annotation of EMA Label for olaparib and BRCA1, BRCA2, ERBB2;Annotation of EMA Label for rucaparib and BRCA1, BRCA2;Annotation of EMA Label for talazoparib and BRCA1, BRCA2, ERBB2;Annotation of FDA Label for niraparib and BRCA1, BRCA2;Annotation of FDA Label for olaparib and BRCA1, BRCA2, ERBB2;Annotation of FDA Label for rucaparib and BRCA1, BRCA2;Annotation of FDA Label for talazoparib and BRCA1, BRCA2;Annotation of HCSC Label for niraparib and BRCA1, BRCA2;Annotation of HCSC Label for olaparib and BRCA1, BRCA2, ERBB2
PA25432	BSCL2	PA166273381	Annotation of EMA Label for metreleptin and AGPAT2, BSCL2, LEP, LMNB2
PA85	CACNA1S	PA166129515;PA166169912;PA166129517;PA166129519;PA166122970;PA166129516;PA166129518;PA166129520	Annotation of FDA Label for desflurane and CACNA1S, RYR1;Annotation of FDA Label for enflurane and CACNA1S, RYR1;Annotation of FDA Label for isoflurane and CACNA1S, RYR1;Annotation of FDA Label for sevoflurane and CACNA1S, RYR1;Annotation of FDA Label for succinylcholine and BCHE, CACNA1S, RYR1;Annotation of HCSC Label for desflurane and CACNA1S, RYR1;Annotation of HCSC Label for isoflurane and CACNA1S, RYR1;Annotation of HCSC Label for sevoflurane and CACNA1S, RYR1
PA26097	CASR	PA166160040	Annotation of FDA Label for Parathyroid Hormones And Analogues and CASR
PA26115	CBL	PA166278181	Annotation of FDA Label for azacitidine and CBL, KRAS, NRAS, PTPN11
PA26123	CBS	PA166293941;PA166293301;PA166293961	Annotation of EMA Label for betaine and CBS, MMADHC, MTHFR;Annotation of FDA Label for betaine and CBS, MMADHC, MTHFR;Annotation of HCSC Label for betaine and CBS, MMADHC, MTHFR
PA26170	CCR5	PA166104803	Annotation of FDA Label for maraviroc and CCR5
PA26192	CD19	PA166159963	Annotation of FDA Label for blinatumomab and ABL1, BCR, CD19
PA134915280	CD274	PA166182926;PA166278421;PA166294041;PA166273521;PA166273301;PA166183249;PA166163429;PA166169877;PA166251421;PA166169884;PA166191581;PA166278121;PA166191561;PA166160009;PA166296361;PA166295581;PA166229941;PA166278442;PA166294083;PA166283821;PA166284721;PA166284642	Annotation of EMA Label for atezolizumab and CD274;Annotation of EMA Label for cemiplimab-rwlc and ALK, CD274, EGFR, ROS1;Annotation of EMA Label for durvalumab and CD274;Annotation of EMA Label for ipilimumab and ALK, CD274, EGFR;Annotation of EMA Label for nivolumab and ALK, CD274, EGFR, ERBB2;Annotation of EMA Label for pembrolizumab and ALK, CD274, EGFR, ERBB2;Annotation of FDA Label for atezolizumab and ALK, BRAF, CD274, EGFR;Annotation of FDA Label for avelumab and CD274;Annotation of FDA Label for cemiplimab-rwlc and ALK, CD274, EGFR, ROS1;Annotation of FDA Label for durvalumab and ALK, CD274, EGFR, PDCD1;Annotation of FDA Label for ipilimumab and ALK, CD274, EGFR;Annotation of FDA Label for nivolumab / relatlimab and BRAF, CD274, LAG3;Annotation of FDA Label for nivolumab and ALK, CD274, EGFR;Annotation of FDA Label for pembrolizumab and ALK, CD274, EGFR, ERBB2;Annotation of FDA Label for pemetrexed and CD274;Annotation of FDA Label for tremelimumab and CD274;Annotation of HCSC Label for atezolizumab and ALK, CD274, EGFR;Annotation of HCSC Label for cemiplimab-rwlc and ALK, CD274, EGFR, ROS1;Annotation of HCSC Label for durvalumab and CD274;Annotation of HCSC Label for ipilimumab and ALK, CD274, EGFR;Annotation of HCSC Label for nivolumab and ALK, CD274, EGFR, ERBB2;Annotation of HCSC Label for pembrolizumab and ALK, CD274, EGFR, ERBB2
PA26210	CD33	PA166283922;PA166224361;PA166284282	Annotation of EMA Label for gemtuzumab ozogamicin and CD33;Annotation of FDA Label for gemtuzumab ozogamicin and CD33;Annotation of HCSC Label for gemtuzumab ozogamicin and CD33
PA26214	CD38	PA166273481	Annotation of EMA Label for isatuximab and CD38
PA36218	CDKL5	PA166278321	Annotation of FDA Label for ganaxolone and CDKL5
PA109	CFTR	PA166283001;PA166182953;PA166182954;PA166104928;PA166190101;PA166152939;PA166179847;PA166104890;PA166283021;PA166127684	Annotation of EMA Label for elexacaftor / tezacaftor / ivacaftor and CFTR;Annotation of EMA Label for ivacaftor / lumacaftor and CFTR;Annotation of EMA Label for ivacaftor / tezacaftor and CFTR;Annotation of EMA Label for ivacaftor and CFTR;Annotation of FDA Label for elexacaftor / tezacaftor / ivacaftor and CFTR;Annotation of FDA Label for ivacaftor / lumacaftor and CFTR;Annotation of FDA Label for ivacaftor / tezacaftor and CFTR;Annotation of FDA Label for ivacaftor and CFTR;Annotation of HCSC Label for elexacaftor / tezacaftor / ivacaftor and CFTR;Annotation of HCSC Label for ivacaftor and CFTR
PA26487	CHRNA1	PA166224221;PA166268901;PA166277881	Annotation of FDA Label for eculizumab and AQP4, CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE;Annotation of FDA Label for efgartigimod alfa and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE;Annotation of FDA Label for ravulizumab and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE
PA113	CHRNA3	PA166224221;PA166268901;PA166277881	Annotation of FDA Label for eculizumab and AQP4, CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE;Annotation of FDA Label for efgartigimod alfa and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE;Annotation of FDA Label for ravulizumab and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE
PA26490	CHRNA4	PA166224221;PA166268901;PA166277881	Annotation of FDA Label for eculizumab and AQP4, CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE;Annotation of FDA Label for efgartigimod alfa and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE;Annotation of FDA Label for ravulizumab and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE
PA26491	CHRNA5	PA166224221;PA166268901;PA166277881	Annotation of FDA Label for eculizumab and AQP4, CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE;Annotation of FDA Label for efgartigimod alfa and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE;Annotation of FDA Label for ravulizumab and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE
PA26492	CHRNA6	PA166224221;PA166268901;PA166277881	Annotation of FDA Label for eculizumab and AQP4, CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE;Annotation of FDA Label for efgartigimod alfa and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE;Annotation of FDA Label for ravulizumab and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE
PA114	CHRNA7	PA166224221;PA166268901;PA166277881	Annotation of FDA Label for eculizumab and AQP4, CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE;Annotation of FDA Label for efgartigimod alfa and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE;Annotation of FDA Label for ravulizumab and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE
PA26494	CHRNB1	PA166224221;PA166268901;PA166277881	Annotation of FDA Label for eculizumab and AQP4, CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE;Annotation of FDA Label for efgartigimod alfa and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE;Annotation of FDA Label for ravulizumab and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE
PA26498	CHRNE	PA166224221;PA166268901;PA166277881	Annotation of FDA Label for eculizumab and AQP4, CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE;Annotation of FDA Label for efgartigimod alfa and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE;Annotation of FDA Label for ravulizumab and CHRNA1, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB1, CHRNE
PA134979958	CPOX	PA166283781;PA166190701;PA166283802	Annotation of EMA Label for givosiran and CPOX, HMBS, PPOX;Annotation of FDA Label for givosiran and CPOX, HMBS, PPOX;Annotation of HCSC Label for givosiran and CPOX, HMBS, PPOX
PA26840	CPS1	PA166269701;PA166114381;PA166269101;PA166104794;PA166114317;PA166283881;PA166127712;PA166123552	Annotation of EMA Label for glycerol phenylbutyrate and ARG1, ASL, ASS1, CPS1, OTC;Annotation of EMA Label for sodium phenylbutyrate and ASS1, CPS1, OTC;Annotation of FDA Label for glycerol phenylbutyrate and ASS1, CPS1, OTC;Annotation of FDA Label for sodium benzoate / sodium phenylacetate and ARG1, ASL, ASS1, CPS1, NAGS, OTC;Annotation of FDA Label for sodium phenylbutyrate and ASS1, CPS1, OTC;Annotation of HCSC Label for glycerol phenylbutyrate and ARG1, ASL, ASS1, CPS1, OTC;Annotation of HCSC Label for sodium phenylbutyrate and ASS1, CPS1, OTC;Annotation of PMDA Label for valproic acid and CPS1, OTC
PA27006	CTLA4	PA166273501	Annotation of EMA Label for ipilimumab and CTLA4, HLA-A
PA134979668	CYB5R1	PA166163430;PA166163431;PA166105195;PA166170934;PA166104783;PA166127702	Annotation of FDA Label for isosorbide dinitrate and CYB5R1, CYB5R2, CYB5R3, CYB5R4;Annotation of FDA Label for isosorbide mononitrate and CYB5R1, CYB5R2, CYB5R3, CYB5R4;Annotation of FDA Label for metoclopramide and CYB5R1, CYB5R2, CYB5R3, CYB5R4, G6PD;Annotation of FDA Label for primaquine and CYB5R1, CYB5R2, CYB5R3, CYB5R4;Annotation of FDA Label for rasburicase and CYB5R1, CYB5R2, CYB5R3, CYB5R4;Annotation of HCSC Label for primaquine and CYB5R1, CYB5R2, CYB5R3, CYB5R4, G6PD
PA142672060	CYB5R2	PA166163430;PA166163431;PA166105195;PA166170934;PA166104783;PA166127702	Annotation of FDA Label for isosorbide dinitrate and CYB5R1, CYB5R2, CYB5R3, CYB5R4;Annotation of FDA Label for isosorbide mononitrate and CYB5R1, CYB5R2, CYB5R3, CYB5R4;Annotation of FDA Label for metoclopramide and CYB5R1, CYB5R2, CYB5R3, CYB5R4, G6PD;Annotation of FDA Label for primaquine and CYB5R1, CYB5R2, CYB5R3, CYB5R4;Annotation of FDA Label for rasburicase and CYB5R1, CYB5R2, CYB5R3, CYB5R4;Annotation of HCSC Label for primaquine and CYB5R1, CYB5R2, CYB5R3, CYB5R4, G6PD
PA27331	CYB5R3	PA166278381;PA166104823;PA166182741;PA166235441;PA166182746;PA166182759;PA166104845;PA166163430;PA166163431;PA166105178;PA166182737;PA166182751;PA166105195;PA166184637;PA166170934;PA166104783;PA166182728;PA166115362;PA166278401;PA166127702	Annotation of EMA Label for bupivacaine and CYB5R3, G6PD;Annotation of EMA Label for methylene blue and BLVRB, CYB5R3, G6PD;Annotation of FDA Label for articaine / epinephrine and CYB5R3, G6PD;Annotation of FDA Label for bupivacaine and CYB5R3, G6PD;Annotation of FDA Label for ceftriaxone and CYB5R3, G6PD;Annotation of FDA Label for chloroprocaine and CYB5R3, G6PD;Annotation of FDA Label for dapsone and CYB5R3, G6PD;Annotation of FDA Label for isosorbide dinitrate and CYB5R1, CYB5R2, CYB5R3, CYB5R4;Annotation of FDA Label for isosorbide mononitrate and CYB5R1, CYB5R2, CYB5R3, CYB5R4;Annotation of FDA Label for lidocaine / prilocaine and CYB5R3, G6PD;Annotation of FDA Label for lidocaine and tetracaine and CYB5R3, G6PD;Annotation of FDA Label for mepivacaine and CYB5R3, G6PD;Annotation of FDA Label for metoclopramide and CYB5R1, CYB5R2, CYB5R3, CYB5R4, G6PD;Annotation of FDA Label for oxymetazoline and tetracaine and BCHE, CYB5R3, G6PD;Annotation of FDA Label for primaquine and CYB5R1, CYB5R2, CYB5R3, CYB5R4;Annotation of FDA Label for rasburicase and CYB5R1, CYB5R2, CYB5R3, CYB5R4;Annotation of FDA Label for ropivacaine and CYB5R3, G6PD;Annotation of FDA Label for sodium nitrite and CYB5R3, G6PD;Annotation of HCSC Label for bupivacaine, meloxicam and CYB5R3, G6PD;Annotation of HCSC Label for primaquine and CYB5R1, CYB5R2, CYB5R3, CYB5R4, G6PD
PA134904907	CYB5R4	PA166163430;PA166163431;PA166105195;PA166170934;PA166104783;PA166127702	Annotation of FDA Label for isosorbide dinitrate and CYB5R1, CYB5R2, CYB5R3, CYB5R4;Annotation of FDA Label for isosorbide mononitrate and CYB5R1, CYB5R2, CYB5R3, CYB5R4;Annotation of FDA Label for metoclopramide and CYB5R1, CYB5R2, CYB5R3, CYB5R4, G6PD;Annotation of FDA Label for primaquine and CYB5R1, CYB5R2, CYB5R3, CYB5R4;Annotation of FDA Label for rasburicase and CYB5R1, CYB5R2, CYB5R3, CYB5R4;Annotation of HCSC Label for primaquine and CYB5R1, CYB5R2, CYB5R3, CYB5R4, G6PD
PA27093	CYP1A2	PA166104915;PA166183424;PA166170935	Annotation of EMA Label for olanzapine and CYP1A2, CYP2D6;Annotation of EMA Label for rucaparib and CYP1A2, CYP2D6;Annotation of FDA Label for rucaparib and CYP1A2, CYP2D6
PA135	CYP27A1	PA166160056	Annotation of FDA Label for cholic acid and AKR1D1, AMACR, CYP27A1, CYP7A1, DHCR7, HSD3B2
PA121	CYP2A6	PA166160717	Annotation of PMDA Label for letrozole and CYP2A6
PA123	CYP2B6	PA166123422;PA166182945;PA166273262;PA166105321;PA166105117;PA166185190;PA166104917;PA166127667;PA166281781;PA166160162;PA166184443;PA166184394	Annotation of EMA Label for efavirenz / emtricitabine / tenofovir disoproxil and CYP2B6;Annotation of EMA Label for efavirenz and CYP2B6;Annotation of EMA Label for ospemifene and CYP2B6;Annotation of EMA Label for prasugrel and CYP2B6, CYP2C19, CYP2C9, CYP3A5;Annotation of FDA Label for efavirenz and CYP2B6;Annotation of FDA Label for ospemifene and CYP2B6, CYP2C9;Annotation of FDA Label for prasugrel and CYP2B6, CYP2C19, CYP2C9, CYP3A5;Annotation of HCSC Label for efavirenz / emtricitabine / tenofovir disoproxil and CYP2B6;Annotation of HCSC Label for ospemifene and CYP2B6, CYP2C9;Annotation of PMDA Label for efavirenz and CYP2B6;Annotation of Swissmedic Label for efavirenz and CYP2B6;Annotation of Swissmedic Label for prasugrel and CYP2B6, CYP2C19, CYP2C9, CYP3A5
PA124	CYP2C19	PA166272981;PA166123421;PA166123387;PA166182932;PA166104841;PA166120286;PA166183171;PA166105321;PA166114382;PA166122826;PA166272961;PA166268882;PA166153492;PA166104832;PA166104852;PA166104884;PA166104777;PA166104863;PA166104784;PA166104820;PA166104814;PA166105012;PA166104816;PA166153432;PA166177509;PA166182766;PA166160049;PA166104898;PA166273021;PA166104808;PA166104921;PA166104901;PA166104860;PA166104917;PA166104848;PA166104851;PA166104818;PA166273001;PA166159707;PA166278001;PA166160289;PA166127650;PA166127653;PA166127661;PA166271481;PA166127670;PA166127698;PA166127706;PA166127730;PA166161536;PA166123535;PA166160669;PA166160720;PA166160846;PA166160856;PA166184380;PA166184123;PA166184125;PA166184133;PA166184445;PA166184382;PA166183900;PA166184159;PA166184222;PA166184394;PA166184396;PA166184238	Annotation of EMA Label for abrocitinib and CYP2C19, CYP2C9;Annotation of EMA Label for atazanavir and CYP2C19;Annotation of EMA Label for axitinib and CYP2C19, UGT1A1;Annotation of EMA Label for brivaracetam and CYP2C19;Annotation of EMA Label for clopidogrel and CYP2C19;Annotation of EMA Label for esomeprazole and CYP2C19;Annotation of EMA Label for lacosamide and CYP2C19;Annotation of EMA Label for prasugrel and CYP2B6, CYP2C19, CYP2C9, CYP3A5;Annotation of EMA Label for ticagrelor and CYP2C19;Annotation of EMA Label for voriconazole and CYP2C19, CYP2C9, CYP3A4;Annotation of FDA Label for abrocitinib and CYP2C19;Annotation of FDA Label for belzutifan and CYP2C19, UGT2B17;Annotation of FDA Label for brivaracetam and CYP2C19;Annotation of FDA Label for carisoprodol and CYP2C19;Annotation of FDA Label for citalopram and CYP2C19;Annotation of FDA Label for clobazam and CYP2C19;Annotation of FDA Label for clopidogrel and CYP2C19;Annotation of FDA Label for dexlansoprazole and CYP2C19;Annotation of FDA Label for diazepam and CYP2C19;Annotation of FDA Label for doxepin and CYP2C19, CYP2D6;Annotation of FDA Label for drospirenone / ethinyl estradiol and CYP2C19;Annotation of FDA Label for escitalopram and CYP2C19;Annotation of FDA Label for esomeprazole and CYP2C19;Annotation of FDA Label for flibanserin and CYP2C19, CYP2C9, CYP2D6;Annotation of FDA Label for formoterol and CYP2C19, CYP2D6;Annotation of FDA Label for fosphenytoin and CYP2C19, CYP2C9, HLA-B;Annotation of FDA Label for lacosamide and CYP2C19;Annotation of FDA Label for lansoprazole and CYP2C19;Annotation of FDA Label for mavacamten and CYP2C19;Annotation of FDA Label for nelfinavir and CYP2C19, CYP3A;Annotation of FDA Label for omeprazole and CYP2C19;Annotation of FDA Label for pantoprazole and CYP2C19;Annotation of FDA Label for phenytoin and CYP2C19, CYP2C9, HLA-B;Annotation of FDA Label for prasugrel and CYP2B6, CYP2C19, CYP2C9, CYP3A5;Annotation of FDA Label for rabeprazole and CYP2C19;Annotation of FDA Label for ticagrelor and CYP2C19;Annotation of FDA Label for voriconazole and CYP2C19;Annotation of HCSC Label for abrocitinib and CYP2C19, CYP2C9;Annotation of HCSC Label for atazanavir and CYP2C19;Annotation of HCSC Label for belzutifan and CYP2C19, UGT2B17;Annotation of HCSC Label for brivaracetam and CYP2C19;Annotation of HCSC Label for citalopram and CYP2C19;Annotation of HCSC Label for clopidogrel and CYP2C19;Annotation of HCSC Label for dexlansoprazole and CYP2C19;Annotation of HCSC Label for escitalopram and CYP2C19;Annotation of HCSC Label for esomeprazole and CYP2C19;Annotation of HCSC Label for omeprazole and CYP2C19;Annotation of HCSC Label for rabeprazole and CYP2C19;Annotation of HCSC Label for voriconazole and CYP2C19;Annotation of PMDA Label for atazanavir and CYP2C19;Annotation of PMDA Label for clopidogrel and CYP2C19;Annotation of PMDA Label for escitalopram and CYP2C19, CYP2D6;Annotation of PMDA Label for omeprazole and CYP2C19;Annotation of PMDA Label for rabeprazole and CYP2C19;Annotation of PMDA Label for voriconazole and CYP2C19;Annotation of Swissmedic Label for brivaracetam and CYP2C19, CYP2C9;Annotation of Swissmedic Label for citalopram and CYP2C19, CYP2D6;Annotation of Swissmedic Label for clopidogrel and CYP2C19;Annotation of Swissmedic Label for dexlansoprazole and CYP2C19;Annotation of Swissmedic Label for escitalopram and CYP2C19;Annotation of Swissmedic Label for lansoprazole and CYP2C19;Annotation of Swissmedic Label for moclobemide and CYP2C19;Annotation of Swissmedic Label for omeprazole and CYP2C19;Annotation of Swissmedic Label for pantoprazole and CYP2C19;Annotation of Swissmedic Label for prasugrel and CYP2B6, CYP2C19, CYP2C9, CYP3A5;Annotation of Swissmedic Label for rabeprazole and CYP2C19;Annotation of Swissmedic Label for voriconazole and CYP2C19
PA126	CYP2C9	PA166272981;PA166240301;PA166183181;PA166269401;PA166273261;PA166105321;PA166272701;PA166272821;PA166122826;PA166184917;PA166104843;PA166163422;PA166182722;PA166153432;PA166104922;PA166182766;PA166160007;PA166182753;PA166269121;PA166185190;PA166104860;PA166105222;PA166104917;PA166225042;PA166182738;PA166104776;PA166273001;PA166127647;PA166284101;PA166284261;PA166283181;PA166281781;PA166278581;PA166127732;PA166160153;PA166183593;PA166184380;PA166184119;PA166184385;PA166184388;PA166184345;PA166184373;PA166184394	Annotation of EMA Label for abrocitinib and CYP2C19, CYP2C9;Annotation of EMA Label for avatrombopag and CYP2C9, F2, F5, PROC, PROS1, SERPINC1;Annotation of EMA Label for lesinurad and CYP2C9;Annotation of EMA Label for nateglinide and CYP2C9;Annotation of EMA Label for ospemifene and CYP2C9;Annotation of EMA Label for prasugrel and CYP2B6, CYP2C19, CYP2C9, CYP3A5;Annotation of EMA Label for rimegepant and CYP2C9;Annotation of EMA Label for siponimod and CYP2C9;Annotation of EMA Label for voriconazole and CYP2C19, CYP2C9, CYP3A4;Annotation of FDA Label for avatrombopag and CYP2C9;Annotation of FDA Label for celecoxib and CYP2C9;Annotation of FDA Label for dronabinol and CYP2C9;Annotation of FDA Label for erdafitinib and CYP2C9;Annotation of FDA Label for flibanserin and CYP2C19, CYP2C9, CYP2D6;Annotation of FDA Label for flurbiprofen and CYP2C9;Annotation of FDA Label for fosphenytoin and CYP2C19, CYP2C9, HLA-B;Annotation of FDA Label for lesinurad and CYP2C9;Annotation of FDA Label for meloxicam and CYP2C9;Annotation of FDA Label for nateglinide and CYP2C9;Annotation of FDA Label for ospemifene and CYP2B6, CYP2C9;Annotation of FDA Label for phenytoin and CYP2C19, CYP2C9, HLA-B;Annotation of FDA Label for piroxicam and CYP2C9;Annotation of FDA Label for prasugrel and CYP2B6, CYP2C19, CYP2C9, CYP3A5;Annotation of FDA Label for rimegepant and CYP2C9;Annotation of FDA Label for siponimod and CYP2C9;Annotation of FDA Label for warfarin and CYP2C9, PROC, PROS1, VKORC1;Annotation of HCSC Label for abrocitinib and CYP2C19, CYP2C9;Annotation of HCSC Label for celecoxib and CYP2C9;Annotation of HCSC Label for erdafitinib and CYP2C9;Annotation of HCSC Label for fosphenytoin and CYP2C9;Annotation of HCSC Label for meloxicam and CYP2C9;Annotation of HCSC Label for ospemifene and CYP2B6, CYP2C9;Annotation of HCSC Label for siponimod and CYP2C9;Annotation of HCSC Label for warfarin and CYP2C9, VKORC1;Annotation of PMDA Label for celecoxib and CYP2C9;Annotation of Swissmedic Label for acenocoumarol and CYP2C9;Annotation of Swissmedic Label for brivaracetam and CYP2C19, CYP2C9;Annotation of Swissmedic Label for celecoxib and CYP2C9;Annotation of Swissmedic Label for lesinurad and CYP2C9;Annotation of Swissmedic Label for losartan and CYP2C9, CYP3A4;Annotation of Swissmedic Label for phenytoin and CYP2C9, HLA-B;Annotation of Swissmedic Label for piroxicam and CYP2C9;Annotation of Swissmedic Label for prasugrel and CYP2B6, CYP2C19, CYP2C9, CYP3A5
PA128	CYP2D6	PA166104899;PA166182930;PA166122966;PA166119827;PA166123414;PA166182944;PA166129447;PA166122967;PA166182950;PA166183219;PA166104915;PA166273241;PA166183248;PA166273101;PA166122487;PA166122947;PA166123410;PA166183424;PA166115435;PA166183441;PA166272181;PA166123408;PA166246301;PA166104856;PA166182729;PA166182730;PA166127662;PA166104839;PA166161219;PA166104827;PA166160054;PA166223861;PA166177479;PA166104813;PA166104787;PA166224101;PA166104875;PA166104815;PA166104916;PA166122971;PA166104862;PA166177483;PA166169882;PA166104886;PA166278361;PA166105113;PA166104820;PA166105010;PA166123487;PA166224121;PA166122972;PA166153432;PA166104788;PA166104835;PA166104854;PA166177509;PA166104869;PA166170929;PA166104887;PA166104879;PA166179848;PA166180000;PA166178750;PA166104836;PA166177514;PA166104868;PA166105028;PA166104880;PA166104888;PA166225161;PA166105211;PA166184539;PA166160052;PA166104864;PA166104893;PA166104870;PA166185168;PA166104837;PA166104798;PA166104812;PA166104811;PA166105232;PA166104793;PA166170935;PA166181925;PA166160672;PA166104822;PA166104829;PA166104805;PA166104830;PA166104806;PA166104799;PA166104857;PA166177521;PA166190761;PA166170052;PA166104847;PA166251601;PA166122607;PA166127628;PA166127631;PA166127633;PA166127646;PA166127654;PA166127659;PA166127673;PA166127675;PA166127691;PA166127697;PA166281761;PA166281741;PA166127704;PA166127708;PA166127718;PA166127719;PA166127721;PA166272241;PA166127731;PA166123528;PA166160226;PA166160709;PA166160669;PA166160712;PA166123541;PA166160845;PA166160850;PA166123549;PA166184127;PA166184109;PA166184111;PA166184405;PA166184118;PA166184123;PA166184124;PA166184126;PA166184130;PA166184131;PA166184134;PA166184442;PA166184444;PA166184446;PA166184447;PA166184452;PA166184453;PA166184454;PA166184455;PA166184374;PA166183790;PA166183810;PA166183910;PA166184160;PA166184172;PA166184177;PA166184220;PA166184221;PA166184223;PA166184395;PA166184402;PA166184421;PA166184428;PA166184392;PA166184404;PA166184422;PA166184425;PA166184426;PA166184236;PA166184231;PA166184232;PA166184234;PA166184239;PA166184490	Annotation of EMA Label for aripiprazole and CYP2D6;Annotation of EMA Label for brexpiprazole and CYP2D6;Annotation of EMA Label for darifenacin and CYP2D6;Annotation of EMA Label for dextromethorphan / quinidine and CYP2D6;Annotation of EMA Label for dronedarone and CYP2D6, CYP3A4;Annotation of EMA Label for duloxetine and CYP2D6;Annotation of EMA Label for eliglustat and CYP2D6;Annotation of EMA Label for fesoterodine and CYP2D6;Annotation of EMA Label for gefitinib and CYP2D6;Annotation of EMA Label for mirabegron and CYP2D6;Annotation of EMA Label for olanzapine and CYP1A2, CYP2D6;Annotation of EMA Label for paliperidone and CYP2D6;Annotation of EMA Label for palonosetron and CYP2D6;Annotation of EMA Label for pitolisant and CYP2D6;Annotation of EMA Label for propranolol and CYP2D6;Annotation of EMA Label for ranolazine and CYP2D6;Annotation of EMA Label for ritonavir and CYP2D6, CYP3A4;Annotation of EMA Label for rucaparib and CYP1A2, CYP2D6;Annotation of EMA Label for timolol and CYP2D6;Annotation of EMA Label for umeclidinium and CYP2D6;Annotation of EMA Label for upadacitinib and CYP2D6;Annotation of EMA Label for vortioxetine and CYP2D6;Annotation of FDA Label for acetaminophen / caffeine / dihydrocodeine and CYP2D6;Annotation of FDA Label for amitriptyline and CYP2D6;Annotation of FDA Label for amoxapine and CYP2D6;Annotation of FDA Label for amphetamine and CYP2D6;Annotation of FDA Label for arformoterol and CYP2D6, UGT1A1;Annotation of FDA Label for aripiprazole and CYP2D6;Annotation of FDA Label for aripiprazole lauroxil and CYP2D6;Annotation of FDA Label for atomoxetine and CYP2D6;Annotation of FDA Label for brexpiprazole and CYP2D6;Annotation of FDA Label for bupropion and CYP2D6;Annotation of FDA Label for cariprazine and CYP2D6;Annotation of FDA Label for carvedilol and CYP2D6;Annotation of FDA Label for cevimeline and CYP2D6;Annotation of FDA Label for citalopram and CYP2D6;Annotation of FDA Label for clomipramine and CYP2D6;Annotation of FDA Label for clozapine and CYP2D6;Annotation of FDA Label for codeine and CYP2D6;Annotation of FDA Label for darifenacin and CYP2D6;Annotation of FDA Label for desipramine and CYP2D6;Annotation of FDA Label for desvenlafaxine and CYP2D6;Annotation of FDA Label for deutetrabenazine and CYP2D6;Annotation of FDA Label for dextromethorphan / quinidine and CYP2D6;Annotation of FDA Label for dextromethorphan hydrobromide / bupropion hydrochloride and CYP2D6;Annotation of FDA Label for donepezil and CYP2D6;Annotation of FDA Label for doxepin and CYP2C19, CYP2D6;Annotation of FDA Label for duloxetine and CYP2D6;Annotation of FDA Label for eliglustat and CYP2D6;Annotation of FDA Label for escitalopram and CYP2D6;Annotation of FDA Label for fesoterodine and CYP2D6;Annotation of FDA Label for flibanserin and CYP2C19, CYP2C9, CYP2D6;Annotation of FDA Label for fluoxetine / olanzapine and CYP2D6;Annotation of FDA Label for fluoxetine and CYP2D6;Annotation of FDA Label for fluvoxamine and CYP2D6;Annotation of FDA Label for formoterol and CYP2C19, CYP2D6;Annotation of FDA Label for galantamine and CYP2D6;Annotation of FDA Label for gefitinib and CYP2D6;Annotation of FDA Label for iloperidone and CYP2D6;Annotation of FDA Label for imipramine and CYP2D6;Annotation of FDA Label for lofexidine and CYP2D6;Annotation of FDA Label for meclizine and CYP2D6;Annotation of FDA Label for metoclopramide and CYP2D6;Annotation of FDA Label for metoprolol and CYP2D6;Annotation of FDA Label for mirabegron and CYP2D6;Annotation of FDA Label for modafinil and CYP2D6;Annotation of FDA Label for nebivolol and CYP2D6;Annotation of FDA Label for nefazodone and CYP2D6;Annotation of FDA Label for nortriptyline and CYP2D6;Annotation of FDA Label for oliceridine and CYP2D6;Annotation of FDA Label for ondansetron and CYP2D6;Annotation of FDA Label for paliperidone and CYP2D6;Annotation of FDA Label for palonosetron and CYP2D6;Annotation of FDA Label for paroxetine and CYP2D6;Annotation of FDA Label for perphenazine and CYP2D6;Annotation of FDA Label for pimozide and CYP2D6;Annotation of FDA Label for pitolisant and CYP2D6;Annotation of FDA Label for propafenone and CYP2D6;Annotation of FDA Label for propranolol and CYP2D6;Annotation of FDA Label for protriptyline and CYP2D6;Annotation of FDA Label for quinidine and CYP2D6;Annotation of FDA Label for quinine and CYP2D6, G6PD;Annotation of FDA Label for risperidone and CYP2D6;Annotation of FDA Label for rucaparib and CYP1A2, CYP2D6;Annotation of FDA Label for tamoxifen and CYP2D6;Annotation of FDA Label for tamsulosin and CYP2D6;Annotation of FDA Label for terbinafine and CYP2D6;Annotation of FDA Label for tetrabenazine and CYP2D6;Annotation of FDA Label for thioridazine and CYP2D6;Annotation of FDA Label for tiotropium and CYP2D6;Annotation of FDA Label for tolterodine and CYP2D6;Annotation of FDA Label for tramadol and CYP2D6;Annotation of FDA Label for trimipramine and CYP2D6;Annotation of FDA Label for umeclidinium and CYP2D6;Annotation of FDA Label for upadacitinib and CYP2D6;Annotation of FDA Label for valbenazine and CYP2D6;Annotation of FDA Label for venlafaxine and CYP2D6;Annotation of FDA Label for viloxazine and CYP2D6;Annotation of FDA Label for vortioxetine and CYP2D6;Annotation of HCSC Label for acetaminophen, tramadol and CYP2D6;Annotation of HCSC Label for aripiprazole and CYP2D6;Annotation of HCSC Label for atomoxetine and CYP2D6;Annotation of HCSC Label for carvedilol and CYP2D6;Annotation of HCSC Label for codeine and CYP2D6;Annotation of HCSC Label for darifenacin and CYP2D6;Annotation of HCSC Label for fesoterodine and CYP2D6;Annotation of HCSC Label for galantamine and CYP2D6;Annotation of HCSC Label for metoprolol and CYP2D6;Annotation of HCSC Label for nortriptyline and CYP2D6;Annotation of HCSC Label for paliperidone and CYP2D6;Annotation of HCSC Label for pitolisant and CYP2D6;Annotation of HCSC Label for propafenone and CYP2D6;Annotation of HCSC Label for risperidone and CYP2D6;Annotation of HCSC Label for tamoxifen and CYP2D6, ESR1, ESR2;Annotation of HCSC Label for tetrabenazine and CYP2D6;Annotation of HCSC Label for tolterodine and CYP2D6;Annotation of HCSC Label for upadacitinib and CYP2D6;Annotation of HCSC Label for vortioxetine and CYP2D6;Annotation of PMDA Label for atomoxetine and CYP2D6;Annotation of PMDA Label for codeine and CYP2D6;Annotation of PMDA Label for eliglustat and CYP2D6;Annotation of PMDA Label for escitalopram and CYP2C19, CYP2D6;Annotation of PMDA Label for fesoterodine and CYP2D6;Annotation of PMDA Label for gefitinib and CYP2D6, EGFR;Annotation of PMDA Label for perphenazine and CYP2D6;Annotation of PMDA Label for tetrabenazine and CYP2D6;Annotation of PMDA Label for tolterodine and CYP2D6;Annotation of Swissmedic Label for acetaminophen / codeine and CYP2D6;Annotation of Swissmedic Label for aripiprazole and CYP2D6;Annotation of Swissmedic Label for atomoxetine and CYP2D6;Annotation of Swissmedic Label for brexpiprazole and CYP2D6;Annotation of Swissmedic Label for carvedilol and CYP2D6;Annotation of Swissmedic Label for citalopram and CYP2C19, CYP2D6;Annotation of Swissmedic Label for clomipramine and CYP2D6;Annotation of Swissmedic Label for codeine and CYP2D6;Annotation of Swissmedic Label for dapoxetine and CYP2D6;Annotation of Swissmedic Label for darifenacin and CYP2D6;Annotation of Swissmedic Label for dextromethorphan and CYP2D6;Annotation of Swissmedic Label for duloxetine and CYP2D6;Annotation of Swissmedic Label for eletriptan and CYP2D6;Annotation of Swissmedic Label for escitalopram and CYP2D6;Annotation of Swissmedic Label for fesoterodine and CYP2D6;Annotation of Swissmedic Label for fluoxetine and CYP2D6;Annotation of Swissmedic Label for fluvoxamine and CYP2D6;Annotation of Swissmedic Label for galantamine and CYP2D6;Annotation of Swissmedic Label for gefitinib and CYP2D6;Annotation of Swissmedic Label for ibrutinib and CYP2D6;Annotation of Swissmedic Label for metoprolol and CYP2D6;Annotation of Swissmedic Label for mirabegron and CYP2D6;Annotation of Swissmedic Label for nebivolol and CYP2D6;Annotation of Swissmedic Label for ondansetron and CYP2D6;Annotation of Swissmedic Label for Opium derivatives and expectorants and CYP2D6;Annotation of Swissmedic Label for oxycodone and CYP2D6;Annotation of Swissmedic Label for paliperidone and CYP2D6;Annotation of Swissmedic Label for palonosetron and CYP2D6;Annotation of Swissmedic Label for Paracetamol, combinations excl. Psycholeptics (Vicks MediNait Sirup) and CYP2D6, G6PD;Annotation of Swissmedic Label for propafenone and CYP2D6;Annotation of Swissmedic Label for ranolazine and CYP2D6;Annotation of Swissmedic Label for risperidone and CYP2D6;Annotation of Swissmedic Label for sertindole and CYP2D6;Annotation of Swissmedic Label for tamoxifen and CYP2D6;Annotation of Swissmedic Label for tamsulosin and CYP2D6, CYP3A4;Annotation of Swissmedic Label for tetrabenazine and CYP2D6;Annotation of Swissmedic Label for tolperisone and CYP2D6;Annotation of Swissmedic Label for tolterodine and CYP2D6, CYP3A4;Annotation of Swissmedic Label for umeclidinium / vilanterol and CYP2D6;Annotation of Swissmedic Label for umeclidinium and CYP2D6;Annotation of Swissmedic Label for venlafaxine and CYP2D6;Annotation of Swissmedic Label for vernakalant and CYP2D6;Annotation of Swissmedic Label for vortioxetine and CYP2D6;Annotation of Swissmedic Label for zuclopenthixol and CYP2D6
PA27114	CYP3A	PA166104808;PA166234801	Annotation of FDA Label for nelfinavir and CYP2C19, CYP3A;Annotation of FDA Label for tacrolimus and CYP3A, CYP3A5
PA130	CYP3A4	PA166123048;PA166123424;PA166123414;PA166123420;PA166123419;PA166123416;PA166105315;PA166123418;PA166123410;PA166123388;PA166123411;PA166123412;PA166123417;PA166123423;PA166122826;PA166123413;PA166184441;PA166184388;PA166184404;PA166184426	Annotation of EMA Label for cabazitaxel and CYP3A4;Annotation of EMA Label for darunavir and CYP3A4;Annotation of EMA Label for dronedarone and CYP2D6, CYP3A4;Annotation of EMA Label for fosamprenavir and CYP3A4;Annotation of EMA Label for indinavir and CYP3A4;Annotation of EMA Label for ivabradine and CYP3A4;Annotation of EMA Label for nelfinavir and CYP3A4;Annotation of EMA Label for posaconazole and CYP3A4;Annotation of EMA Label for ritonavir and CYP2D6, CYP3A4;Annotation of EMA Label for ruxolitinib and CYP3A4;Annotation of EMA Label for sirolimus and CYP3A4;Annotation of EMA Label for sunitinib and CYP3A4;Annotation of EMA Label for telithromycin and CYP3A4;Annotation of EMA Label for tipranavir and CYP3A4;Annotation of EMA Label for voriconazole and CYP2C19, CYP2C9, CYP3A4;Annotation of EMA Label for zonisamide and CYP3A4;Annotation of Swissmedic Label for dolutegravir and CYP3A4, CYP3A5, NR1I2, UGT1A1;Annotation of Swissmedic Label for losartan and CYP2C9, CYP3A4;Annotation of Swissmedic Label for tamsulosin and CYP2D6, CYP3A4;Annotation of Swissmedic Label for tolterodine and CYP2D6, CYP3A4
PA131	CYP3A5	PA166105321;PA166104917;PA166234801;PA166184441;PA166183590;PA166184394	Annotation of EMA Label for prasugrel and CYP2B6, CYP2C19, CYP2C9, CYP3A5;Annotation of FDA Label for prasugrel and CYP2B6, CYP2C19, CYP2C9, CYP3A5;Annotation of FDA Label for tacrolimus and CYP3A, CYP3A5;Annotation of Swissmedic Label for dolutegravir and CYP3A4, CYP3A5, NR1I2, UGT1A1;Annotation of Swissmedic Label for maraviroc and CYP3A5;Annotation of Swissmedic Label for prasugrel and CYP2B6, CYP2C19, CYP2C9, CYP3A5
PA132	CYP7A1	PA166160056	Annotation of FDA Label for cholic acid and AKR1D1, AMACR, CYP27A1, CYP7A1, DHCR7, HSD3B2
PA27321	DHCR7	PA166160056	Annotation of FDA Label for cholic acid and AKR1D1, AMACR, CYP27A1, CYP7A1, DHCR7, HSD3B2
PA27378	DMD	PA166251561;PA166163433;PA166190741;PA166236521	Annotation of FDA Label for casimersen and DMD;Annotation of FDA Label for eteplirsen and DMD;Annotation of FDA Label for golodirsen and DMD;Annotation of FDA Label for viltolarsen and DMD
PA145	DPYD	PA166104905;PA166271261;PA166104802;PA166104807;PA166127644;PA166127674;PA166123531;PA166123539;PA166184114;PA166184449;PA166184108;PA166184450	Annotation of EMA Label for capecitabine and DPYD;Annotation of EMA Label for tegafur / gimeracil / oteracil and DPYD;Annotation of FDA Label for capecitabine and DPYD;Annotation of FDA Label for fluorouracil and DPYD;Annotation of HCSC Label for capecitabine and DPYD;Annotation of HCSC Label for fluorouracil and DPYD;Annotation of PMDA Label for capecitabine and DPYD;Annotation of PMDA Label for fluorouracil and DPYD;Annotation of Swissmedic Label for capecitabine and DPYD;Annotation of Swissmedic Label for flucytosine and DPYD;Annotation of Swissmedic Label for fluorouracil / salicylic acid and DPYD;Annotation of Swissmedic Label for fluorouracil and DPYD
PA7360	EGFR	PA166119823;PA166278421;PA166104908;PA166182942;PA166104844;PA166104930;PA166273521;PA166273301;PA166183246;PA166183249;PA166227141;PA166114903;PA166163429;PA166251421;PA166104826;PA166182280;PA166169884;PA166104785;PA166104789;PA166191581;PA166268941;PA166191561;PA166131627;PA166104809;PA166160009;PA166296341;PA166184560;PA166114944;PA166252901;PA166293341;PA166127629;PA166229941;PA166278442;PA166127648;PA166127669;PA166127676;PA166283821;PA166284721;PA166127699;PA166284642;PA166284701;PA166160274;PA166160710;PA166123541	Annotation of EMA Label for afatinib and EGFR;Annotation of EMA Label for cemiplimab-rwlc and ALK, CD274, EGFR, ROS1;Annotation of EMA Label for cetuximab and EGFR, KRAS, NRAS;Annotation of EMA Label for dacomitinib and EGFR;Annotation of EMA Label for erlotinib and EGFR;Annotation of EMA Label for gefitinib and EGFR;Annotation of EMA Label for ipilimumab and ALK, CD274, EGFR;Annotation of EMA Label for nivolumab and ALK, CD274, EGFR, ERBB2;Annotation of EMA Label for osimertinib and EGFR;Annotation of EMA Label for pembrolizumab and ALK, CD274, EGFR, ERBB2;Annotation of EMA Label for ramucirumab and EGFR;Annotation of FDA Label for afatinib and EGFR;Annotation of FDA Label for atezolizumab and ALK, BRAF, CD274, EGFR;Annotation of FDA Label for cemiplimab-rwlc and ALK, CD274, EGFR, ROS1;Annotation of FDA Label for cetuximab and EGFR, KRAS, NRAS;Annotation of FDA Label for dacomitinib and EGFR;Annotation of FDA Label for durvalumab and ALK, CD274, EGFR, PDCD1;Annotation of FDA Label for erlotinib and EGFR;Annotation of FDA Label for gefitinib and EGFR;Annotation of FDA Label for ipilimumab and ALK, CD274, EGFR;Annotation of FDA Label for mobocertinib and EGFR;Annotation of FDA Label for nivolumab and ALK, CD274, EGFR;Annotation of FDA Label for osimertinib and EGFR;Annotation of FDA Label for panitumumab and EGFR, KRAS, NRAS;Annotation of FDA Label for pembrolizumab and ALK, CD274, EGFR, ERBB2;Annotation of FDA Label for pemetrexed and ALK, EGFR;Annotation of FDA Label for ramucirumab and ALK, EGFR;Annotation of FDA Label for regorafenib and EGFR, KRAS, VEGFA;Annotation of FDA Label for tepotinib and ALK, EGFR;Annotation of FDA Label for tremelimumab and ALK, EGFR;Annotation of HCSC Label for afatinib and EGFR;Annotation of HCSC Label for atezolizumab and ALK, CD274, EGFR;Annotation of HCSC Label for cemiplimab-rwlc and ALK, CD274, EGFR, ROS1;Annotation of HCSC Label for cetuximab and EGFR, KRAS;Annotation of HCSC Label for erlotinib and EGFR;Annotation of HCSC Label for gefitinib and EGFR;Annotation of HCSC Label for ipilimumab and ALK, CD274, EGFR;Annotation of HCSC Label for nivolumab and ALK, CD274, EGFR, ERBB2;Annotation of HCSC Label for panitumumab and EGFR, KRAS;Annotation of HCSC Label for pembrolizumab and ALK, CD274, EGFR, ERBB2;Annotation of HCSC Label for regorafenib and EGFR, KRAS, VEGFA;Annotation of PMDA Label for cetuximab and EGFR, KRAS;Annotation of PMDA Label for erlotinib and EGFR;Annotation of PMDA Label for gefitinib and CYP2D6, EGFR
PA27844	ERBB2	PA166182923;PA166227181;PA166104911;PA166104919;PA166104840;PA166183220;PA166273301;PA166183243;PA166183247;PA166183249;PA166122066;PA166183421;PA166183425;PA166272681;PA166114481;PA166283941;PA166122547;PA166272201;PA166177475;PA166184524;PA166293201;PA166182725;PA166104913;PA166182724;PA166104791;PA166235881;PA166177516;PA166160121;PA166159964;PA166160133;PA166160009;PA166104889;PA166170048;PA166182752;PA166184636;PA166104920;PA166190643;PA166104796;PA166225142;PA166272661;PA166227201;PA166127671;PA166127685;PA166284721;PA166282882;PA166284642;PA166127700;PA166272321;PA166127724;PA166284121;PA166127723;PA166272221;PA166160711;PA166123544;PA166123550	Annotation of EMA Label for abemaciclib and ERBB2, ESR1, ESR2, PGR;Annotation of EMA Label for alpelisib and ERBB2, ESR1, ESR2, PIK3CA;Annotation of EMA Label for everolimus and ERBB2, ESR1, ESR2;Annotation of EMA Label for fulvestrant and ERBB2, ESR1, ESR2, PGR;Annotation of EMA Label for lapatinib and ERBB2, ESR1, ESR2;Annotation of EMA Label for neratinib and ERBB2, ESR1, ESR2, PGR;Annotation of EMA Label for nivolumab and ALK, CD274, EGFR, ERBB2;Annotation of EMA Label for olaparib and BRCA1, BRCA2, ERBB2;Annotation of EMA Label for palbociclib and ERBB2, ESR1, ESR2, PGR;Annotation of EMA Label for pembrolizumab and ALK, CD274, EGFR, ERBB2;Annotation of EMA Label for pertuzumab and ERBB2;Annotation of EMA Label for ribociclib and ERBB2, ESR1, ESR2, PGR;Annotation of EMA Label for talazoparib and BRCA1, BRCA2, ERBB2;Annotation of EMA Label for tipiracil / trifluridine and ERBB2, KRAS;Annotation of EMA Label for trastuzumab and ERBB2;Annotation of EMA Label for trastuzumab deruxtecan and ERBB2;Annotation of EMA Label for trastuzumab emtansine and ERBB2;Annotation of EMA Label for tucatinib and ERBB2;Annotation of FDA Label for abemaciclib and ERBB2, ESR1, ESR2, MKI67, PGR;Annotation of FDA Label for alpelisib and ERBB2, ESR1, ESR2, PIK3CA;Annotation of FDA Label for capecitabine and ERBB2;Annotation of FDA Label for eribulin and ERBB2, ESR1, ESR2, PGR;Annotation of FDA Label for everolimus and ERBB2, ESR1, ESR2;Annotation of FDA Label for ixabepilone and ERBB2, ESR1, ESR2, PGR;Annotation of FDA Label for lapatinib and ERBB2, ESR1, ESR2, PGR;Annotation of FDA Label for margetuximab and ERBB2;Annotation of FDA Label for neratinib and ERBB2;Annotation of FDA Label for nivolumab and BRAF, ERBB2;Annotation of FDA Label for olaparib and BRCA1, BRCA2, ERBB2;Annotation of FDA Label for palbociclib and ERBB2, ESR1, ESR2;Annotation of FDA Label for pembrolizumab and ALK, CD274, EGFR, ERBB2;Annotation of FDA Label for pertuzumab and ERBB2;Annotation of FDA Label for ribociclib and ERBB2, ESR1, ESR2, PGR;Annotation of FDA Label for talazoparib and ERBB2;Annotation of FDA Label for tipiracil / trifluridine and ERBB2, KRAS;Annotation of FDA Label for trastuzumab and ERBB2;Annotation of FDA Label for trastuzumab deruxtecan and ERBB2;Annotation of FDA Label for trastuzumab emtansine and ERBB2;Annotation of FDA Label for tucatinib and ERBB2;Annotation of HCSC Label for abemaciclib and ERBB2, ESR1, ESR2;Annotation of HCSC Label for alpelisib and ERBB2, ESR1, ESR2, PIK3CA;Annotation of HCSC Label for everolimus and ERBB2, ESR1, ESR2;Annotation of HCSC Label for lapatinib and ERBB2, HLA-DQA1, HLA-DRB1;Annotation of HCSC Label for nivolumab and ALK, CD274, EGFR, ERBB2;Annotation of HCSC Label for olaparib and BRCA1, BRCA2, ERBB2;Annotation of HCSC Label for pembrolizumab and ALK, CD274, EGFR, ERBB2;Annotation of HCSC Label for pertuzumab and ERBB2;Annotation of HCSC Label for tipiracil / trifluridine and ERBB2, KRAS;Annotation of HCSC Label for trastuzumab and ERBB2;Annotation of HCSC Label for trastuzumab deruxtecan and ERBB2;Annotation of HCSC Label for trastuzumab emtansine and ERBB2;Annotation of HCSC Label for tucatinib and ERBB2;Annotation of PMDA Label for everolimus and ERBB2, ESR1, ESR2;Annotation of PMDA Label for lapatinib and ERBB2, HLA-DQA1, HLA-DRB1;Annotation of PMDA Label for trastuzumab and ERBB2
PA156	ESR1	PA166182923;PA166227181;PA166104911;PA166104919;PA166104840;PA166183220;PA166183247;PA166183421;PA166182789;PA166177475;PA166184524;PA166105070;PA166182760;PA166182725;PA166104913;PA166104923;PA166104792;PA166182758;PA166182724;PA166104791;PA166104797;PA166178724;PA166182890;PA166160133;PA166170933;PA166185194;PA166170048;PA166104819;PA166182750;PA166170939;PA166293681;PA166272661;PA166227201;PA166127630;PA166127671;PA166127672;PA166127687;PA166127718;PA166160711;PA166123540	Annotation of EMA Label for abemaciclib and ERBB2, ESR1, ESR2, PGR;Annotation of EMA Label for alpelisib and ERBB2, ESR1, ESR2, PIK3CA;Annotation of EMA Label for everolimus and ERBB2, ESR1, ESR2;Annotation of EMA Label for fulvestrant and ERBB2, ESR1, ESR2, PGR;Annotation of EMA Label for lapatinib and ERBB2, ESR1, ESR2;Annotation of EMA Label for neratinib and ERBB2, ESR1, ESR2, PGR;Annotation of EMA Label for palbociclib and ERBB2, ESR1, ESR2, PGR;Annotation of EMA Label for ribociclib and ERBB2, ESR1, ESR2, PGR;Annotation of EMA Label for toremifene and ESR1, ESR2;Annotation of FDA Label for abemaciclib and ERBB2, ESR1, ESR2, MKI67, PGR;Annotation of FDA Label for alpelisib and ERBB2, ESR1, ESR2, PIK3CA;Annotation of FDA Label for anastrozole and ESR1, ESR2, PGR;Annotation of FDA Label for docetaxel and ESR1, ESR2, PGR;Annotation of FDA Label for eribulin and ERBB2, ESR1, ESR2, PGR;Annotation of FDA Label for everolimus and ERBB2, ESR1, ESR2;Annotation of FDA Label for exemestane and ESR1, ESR2, PGR;Annotation of FDA Label for fulvestrant and ESR1, ESR2, PGR;Annotation of FDA Label for goserelin and ESR1, ESR2, PGR;Annotation of FDA Label for ixabepilone and ERBB2, ESR1, ESR2, PGR;Annotation of FDA Label for lapatinib and ERBB2, ESR1, ESR2, PGR;Annotation of FDA Label for letrozole and ESR1, ESR2, PGR;Annotation of FDA Label for neratinib and ESR1, ESR2, PGR;Annotation of FDA Label for olaparib and ESR1, ESR2, PGR, PPP2R2A;Annotation of FDA Label for palbociclib and ERBB2, ESR1, ESR2;Annotation of FDA Label for pertuzumab and ESR1, ESR2, PGR;Annotation of FDA Label for raloxifene and ESR1, ESR2;Annotation of FDA Label for ribociclib and ERBB2, ESR1, ESR2, PGR;Annotation of FDA Label for tamoxifen and ESR1, ESR2, PGR;Annotation of FDA Label for toremifene and ESR1, ESR2;Annotation of FDA Label for trastuzumab and ESR1, ESR2, PGR;Annotation of FDA Label for trastuzumab deruxtecan and ESR1, ESR2;Annotation of HCSC Label for abemaciclib and ERBB2, ESR1, ESR2;Annotation of HCSC Label for alpelisib and ERBB2, ESR1, ESR2, PIK3CA;Annotation of HCSC Label for anastrozole and ESR1, ESR2, PGR;Annotation of HCSC Label for everolimus and ERBB2, ESR1, ESR2;Annotation of HCSC Label for exemestane and ESR1, ESR2;Annotation of HCSC Label for letrozole and ESR1, ESR2, PGR;Annotation of HCSC Label for tamoxifen and CYP2D6, ESR1, ESR2;Annotation of PMDA Label for everolimus and ERBB2, ESR1, ESR2;Annotation of PMDA Label for fulvestrant and ESR1, ESR2
PA27886	ESR2	PA166182923;PA166227181;PA166104911;PA166104919;PA166104840;PA166183220;PA166183247;PA166183421;PA166182789;PA166177475;PA166184524;PA166105070;PA166182760;PA166182725;PA166104913;PA166104923;PA166104792;PA166182758;PA166182724;PA166104791;PA166104797;PA166178724;PA166182890;PA166160133;PA166170933;PA166185194;PA166170048;PA166104819;PA166182750;PA166170939;PA166293681;PA166272661;PA166227201;PA166127630;PA166127671;PA166127672;PA166127687;PA166127718;PA166160711;PA166123540	Annotation of EMA Label for abemaciclib and ERBB2, ESR1, ESR2, PGR;Annotation of EMA Label for alpelisib and ERBB2, ESR1, ESR2, PIK3CA;Annotation of EMA Label for everolimus and ERBB2, ESR1, ESR2;Annotation of EMA Label for fulvestrant and ERBB2, ESR1, ESR2, PGR;Annotation of EMA Label for lapatinib and ERBB2, ESR1, ESR2;Annotation of EMA Label for neratinib and ERBB2, ESR1, ESR2, PGR;Annotation of EMA Label for palbociclib and ERBB2, ESR1, ESR2, PGR;Annotation of EMA Label for ribociclib and ERBB2, ESR1, ESR2, PGR;Annotation of EMA Label for toremifene and ESR1, ESR2;Annotation of FDA Label for abemaciclib and ERBB2, ESR1, ESR2, MKI67, PGR;Annotation of FDA Label for alpelisib and ERBB2, ESR1, ESR2, PIK3CA;Annotation of FDA Label for anastrozole and ESR1, ESR2, PGR;Annotation of FDA Label for docetaxel and ESR1, ESR2, PGR;Annotation of FDA Label for eribulin and ERBB2, ESR1, ESR2, PGR;Annotation of FDA Label for everolimus and ERBB2, ESR1, ESR2;Annotation of FDA Label for exemestane and ESR1, ESR2, PGR;Annotation of FDA Label for fulvestrant and ESR1, ESR2, PGR;Annotation of FDA Label for goserelin and ESR1, ESR2, PGR;Annotation of FDA Label for ixabepilone and ERBB2, ESR1, ESR2, PGR;Annotation of FDA Label for lapatinib and ERBB2, ESR1, ESR2, PGR;Annotation of FDA Label for letrozole and ESR1, ESR2, PGR;Annotation of FDA Label for neratinib and ESR1, ESR2, PGR;Annotation of FDA Label for olaparib and ESR1, ESR2, PGR, PPP2R2A;Annotation of FDA Label for palbociclib and ERBB2, ESR1, ESR2;Annotation of FDA Label for pertuzumab and ESR1, ESR2, PGR;Annotation of FDA Label for raloxifene and ESR1, ESR2;Annotation of FDA Label for ribociclib and ERBB2, ESR1, ESR2, PGR;Annotation of FDA Label for tamoxifen and ESR1, ESR2, PGR;Annotation of FDA Label for toremifene and ESR1, ESR2;Annotation of FDA Label for trastuzumab and ESR1, ESR2, PGR;Annotation of FDA Label for trastuzumab deruxtecan and ESR1, ESR2;Annotation of HCSC Label for abemaciclib and ERBB2, ESR1, ESR2;Annotation of HCSC Label for alpelisib and ERBB2, ESR1, ESR2, PIK3CA;Annotation of HCSC Label for anastrozole and ESR1, ESR2, PGR;Annotation of HCSC Label for everolimus and ERBB2, ESR1, ESR2;Annotation of HCSC Label for exemestane and ESR1, ESR2;Annotation of HCSC Label for letrozole and ESR1, ESR2, PGR;Annotation of HCSC Label for tamoxifen and CYP2D6, ESR1, ESR2;Annotation of PMDA Label for everolimus and ERBB2, ESR1, ESR2;Annotation of PMDA Label for fulvestrant and ESR1, ESR2
PA157	F2	PA166240301;PA166179855;PA166182749;PA166170936;PA166127695	Annotation of EMA Label for avatrombopag and CYP2C9, F2, F5, PROC, PROS1, SERPINC1;Annotation of FDA Label for avatrombopag and F2, F5, PROC, PROS1, SERPINC1;Annotation of FDA Label for lusutrombopag and F2, F5, PROC, PROS1, SERPINC1;Annotation of FDA Label for tamoxifen and F2, F5;Annotation of HCSC Label for ethinyl estradiol / norelgestromin and F2, F5, MTHFR, PROC, PROS1, SERPINC1
PA159	F5	PA166240301;PA166104907;PA166120287;PA166179855;PA166104912;PA166182749;PA166182726;PA166170936;PA166127666;PA166127668;PA166127695	Annotation of EMA Label for avatrombopag and CYP2C9, F2, F5, PROC, PROS1, SERPINC1;Annotation of EMA Label for eltrombopag and F5, SERPINC1;Annotation of EMA Label for ethinyl estradiol / norelgestromin and F5, PROC, PROS1, SERPINC1;Annotation of FDA Label for avatrombopag and F2, F5, PROC, PROS1, SERPINC1;Annotation of FDA Label for eltrombopag and F5, SERPINC1;Annotation of FDA Label for lusutrombopag and F2, F5, PROC, PROS1, SERPINC1;Annotation of FDA Label for rivaroxaban and F5;Annotation of FDA Label for tamoxifen and F2, F5;Annotation of HCSC Label for drospirenone / ethinyl estradiol and F5, PROC, PROS1, SERPINC1;Annotation of HCSC Label for eltrombopag and F5, SERPINC1;Annotation of HCSC Label for ethinyl estradiol / norelgestromin and F2, F5, MTHFR, PROC, PROS1, SERPINC1
PA27952	F8	PA166293361;PA166293981	Annotation of FDA Label for desmopressin and F8;Annotation of HCSC Label for desmopressin and F8
PA28063	FCGR2A	PA166235901	Annotation of FDA Label for margetuximab and FCGR2A, FCGR2B, FCGR3A
PA28064	FCGR2B	PA166235901	Annotation of FDA Label for margetuximab and FCGR2A, FCGR2B, FCGR3A
PA28065	FCGR3A	PA166235901	Annotation of FDA Label for margetuximab and FCGR2A, FCGR2B, FCGR3A
PA28127	FGFR1	PA166293421	Annotation of FDA Label for pemigatinib and FGFR1, FGFR2
PA28128	FGFR2	PA166294981;PA166182721;PA166293401;PA166252081;PA166293421;PA166284081;PA166283841;PA166295001	Annotation of EMA Label for pemigatinib and FGFR2;Annotation of FDA Label for erdafitinib and FGFR2, FGFR3;Annotation of FDA Label for futibatinib and FGFR2;Annotation of FDA Label for infigratinib and FGFR2;Annotation of FDA Label for pemigatinib and FGFR1, FGFR2;Annotation of HCSC Label for erdafitinib and FGFR2, FGFR3;Annotation of HCSC Label for infigratinib and FGFR2;Annotation of HCSC Label for pemigatinib and FGFR2
PA28129	FGFR3	PA166182721;PA166284081	Annotation of FDA Label for erdafitinib and FGFR2, FGFR3;Annotation of HCSC Label for erdafitinib and FGFR2, FGFR3
PA134875694	FIP1L1	PA166104926;PA166104790;PA166127682	Annotation of EMA Label for imatinib and ABL1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB;Annotation of FDA Label for imatinib and ABL1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB;Annotation of HCSC Label for imatinib and ABI1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB
PA28181	FLT3	PA166183200;PA166272161;PA166182768;PA166169918;PA166163420;PA166272261	Annotation of EMA Label for midostaurin and FLT3;Annotation of EMA Label for venetoclax and FLT3, IDH1, IDH2, NPM1, TP53;Annotation of FDA Label for gilteritinib and FLT3;Annotation of FDA Label for midostaurin and FLT3;Annotation of FDA Label for venetoclax and FLT3, IDH1, IDH2, NPM1, TP53;Annotation of HCSC Label for venetoclax and FLT3, IDH1, IDH2, NPM1, TP53
PA28205	FOLH1	PA166278161	Annotation of FDA Label for lutetium (177lu) vipivotide tetraxetan and FOLH1
PA28207	FOLR1	PA166293742	Annotation of FDA Label for mirvetuximab soravtansine and FOLR1
PA28469	G6PD	PA166278381;PA166182951;PA166120370;PA166183183;PA166104823;PA166121327;PA166104894;PA166182741;PA166293282;PA166235441;PA166182746;PA166182759;PA166104786;PA166114910;PA166114913;PA166104845;PA166104895;PA166182765;PA166104881;PA166105147;PA166105148;PA166182769;PA166105178;PA166182737;PA166114926;PA166182751;PA166104878;PA166105195;PA166104897;PA166104891;PA166104903;PA166104885;PA166184637;PA166104900;PA166104876;PA166104906;PA166105232;PA166151881;PA166182728;PA166115362;PA166115363;PA166104902;PA166104874;PA166104892;PA166182739;PA166182786;PA166182787;PA166170937;PA166278401;PA166127649;PA166127657;PA166127717;PA166127677;PA166127678;PA166127729;PA166127694;PA166127696;PA166127702;PA166127705;PA166127707;PA166129528;PA166127714;PA166127715;PA166127716;PA166182788;PA166160683;PA166160718;PA166160854;PA166160719;PA166123548;PA166160847;PA166160848;PA166160849;PA166184128;PA166184224;PA166183786;PA166184423;PA166183782;PA166184113;PA166184117;PA166184121;PA166184122;PA166184456;PA166184457;PA166184458;PA166184461;PA166183621;PA166183789;PA166183901;PA166184082;PA166184155;PA166184459;PA166184156;PA166184157;PA166184223;PA166184286;PA166184381;PA166184120;PA166184403;PA166184389;PA166184390;PA166184391;PA166184237;PA166184110	Annotation of EMA Label for bupivacaine and CYB5R3, G6PD;Annotation of EMA Label for glyburide and G6PD;Annotation of EMA Label for glimepiride, pioglitazone and G6PD;Annotation of EMA Label for lidocaine / prilocaine and G6PD;Annotation of EMA Label for methylene blue and BLVRB, CYB5R3, G6PD;Annotation of EMA Label for pegloticase and G6PD;Annotation of EMA Label for rasburicase and G6PD;Annotation of FDA Label for articaine / epinephrine and CYB5R3, G6PD;Annotation of FDA Label for Ascorbic acid (vitamin C), combinations, Ascorbic acid (vitamin C), plain, sodium ascorbate and G6PD;Annotation of FDA Label for bupivacaine and CYB5R3, G6PD;Annotation of FDA Label for ceftriaxone and CYB5R3, G6PD;Annotation of FDA Label for chloroprocaine and CYB5R3, G6PD;Annotation of FDA Label for chloroquine and G6PD;Annotation of FDA Label for chlorpropamide and G6PD;Annotation of FDA Label for dabrafenib and G6PD;Annotation of FDA Label for dapsone and CYB5R3, G6PD;Annotation of FDA Label for erythromycin ethylsuccinate / sulfisoxazole acetyl and G6PD;Annotation of FDA Label for flutamide and G6PD;Annotation of FDA Label for glyburide and G6PD;Annotation of FDA Label for glimepiride and G6PD;Annotation of FDA Label for glipizide and G6PD;Annotation of FDA Label for hydroxychloroquine and G6PD;Annotation of FDA Label for lidocaine / prilocaine and CYB5R3, G6PD;Annotation of FDA Label for lidocaine and tetracaine and CYB5R3, G6PD;Annotation of FDA Label for mafenide and G6PD;Annotation of FDA Label for mepivacaine and CYB5R3, G6PD;Annotation of FDA Label for methylene blue and G6PD;Annotation of FDA Label for metoclopramide and CYB5R1, CYB5R2, CYB5R3, CYB5R4, G6PD;Annotation of FDA Label for moviprep and G6PD;Annotation of FDA Label for nalidixic acid and G6PD;Annotation of FDA Label for nitrofurantoin and G6PD;Annotation of FDA Label for norfloxacin and G6PD;Annotation of FDA Label for oxymetazoline and tetracaine and BCHE, CYB5R3, G6PD;Annotation of FDA Label for pegloticase and G6PD;Annotation of FDA Label for primaquine and G6PD;Annotation of FDA Label for probenecid and G6PD;Annotation of FDA Label for quinine and CYP2D6, G6PD;Annotation of FDA Label for rasburicase and G6PD;Annotation of FDA Label for ropivacaine and CYB5R3, G6PD;Annotation of FDA Label for sodium nitrite and CYB5R3, G6PD;Annotation of FDA Label for succimer and G6PD;Annotation of FDA Label for sulfadiazine and G6PD;Annotation of FDA Label for sulfamethoxazole / trimethoprim and G6PD, NAT2;Annotation of FDA Label for sulfasalazine and G6PD, NAT2;Annotation of FDA Label for tafenoquine and G6PD;Annotation of FDA Label for tolazamide and G6PD;Annotation of FDA Label for tolbutamide and G6PD;Annotation of FDA Label for trametinib and G6PD;Annotation of HCSC Label for bupivacaine, meloxicam and CYB5R3, G6PD;Annotation of HCSC Label for chlorpropamide and G6PD;Annotation of HCSC Label for dapsone and G6PD;Annotation of HCSC Label for erythromycin ethylsuccinate / sulfisoxazole acetyl and G6PD;Annotation of HCSC Label for glyburide and G6PD;Annotation of HCSC Label for glimepiride and G6PD;Annotation of HCSC Label for moviprep and G6PD;Annotation of HCSC Label for nitrofurantoin and G6PD;Annotation of HCSC Label for norfloxacin and G6PD;Annotation of HCSC Label for primaquine and CYB5R1, CYB5R2, CYB5R3, CYB5R4, G6PD;Annotation of HCSC Label for quinine and G6PD;Annotation of HCSC Label for rasburicase and G6PD;Annotation of HCSC Label for sodium nitrite and G6PD;Annotation of HCSC Label for sulfadiazine and G6PD;Annotation of HCSC Label for sulfamethoxazole / trimethoprim and G6PD;Annotation of HCSC Label for sulfasalazine and G6PD;Annotation of HCSC Label for tolbutamide and G6PD;Annotation of PMDA Label for dapsone and G6PD;Annotation of PMDA Label for methylene blue and BLVRB, G6PD;Annotation of PMDA Label for moviprep and G6PD;Annotation of PMDA Label for nalidixic acid and G6PD;Annotation of PMDA Label for rasburicase and G6PD;Annotation of PMDA Label for sulfadiazine and G6PD;Annotation of PMDA Label for sulfamethoxazole / trimethoprim and G6PD;Annotation of PMDA Label for sulfasalazine and G6PD;Annotation of Swissmedic Label for acetaminophen / codeine and G6PD;Annotation of Swissmedic Label for acetaminophen, acetaminophen / tramadol and G6PD;Annotation of Swissmedic Label for amlodipine / atorvastatin / perindopril arginine and G6PD, SLCO1B1;Annotation of Swissmedic Label for antithrombotic agents and G6PD;Annotation of Swissmedic Label for aspirin and G6PD;Annotation of Swissmedic Label for bisoprolol fumarate / perindopril arginine and G6PD;Annotation of Swissmedic Label for carbasalate calcium and G6PD;Annotation of Swissmedic Label for chloroquine and G6PD;Annotation of Swissmedic Label for ciprofloxacin and G6PD;Annotation of Swissmedic Label for glyburide and G6PD;Annotation of Swissmedic Label for gliclazide and G6PD;Annotation of Swissmedic Label for glimepiride and G6PD;Annotation of Swissmedic Label for hydroxychloroquine and G6PD;Annotation of Swissmedic Label for mefloquine and G6PD;Annotation of Swissmedic Label for metabutethamine and G6PD;Annotation of Swissmedic Label for moxifloxacin and G6PD;Annotation of Swissmedic Label for nicorandil and G6PD;Annotation of Swissmedic Label for nitrofurantoin and G6PD;Annotation of Swissmedic Label for nitroglycerin and G6PD;Annotation of Swissmedic Label for norfloxacin and G6PD;Annotation of Swissmedic Label for ofloxacin and G6PD;Annotation of Swissmedic Label for Paracetamol, combinations excl. Psycholeptics (Vicks MediNait Sirup) and CYP2D6, G6PD;Annotation of Swissmedic Label for perindopril and G6PD;Annotation of Swissmedic Label for prilocaine and G6PD;Annotation of Swissmedic Label for quinine and G6PD;Annotation of Swissmedic Label for rasburicase and G6PD;Annotation of Swissmedic Label for sulfadiazine and G6PD;Annotation of Swissmedic Label for sulfamethoxazole / trimethoprim and G6PD;Annotation of Swissmedic Label for sulfasalazine and G6PD;Annotation of Swissmedic Label for Vitamin B-complex with vitamin C and G6PD;Annotation of Swissmedic Label for vitamin c and G6PD
PA28476	GAA	PA166227101;PA166223902;PA166227121	Annotation of EMA Label for alglucosidase alfa and GAA;Annotation of FDA Label for alglucosidase alfa and GAA;Annotation of HCSC Label for alglucosidase alfa and GAA
PA28535	GALNS	PA166182947;PA166159064	Annotation of EMA Label for elosulfase alfa and GALNS;Annotation of FDA Label for elosulfase alfa and GALNS
PA28591	GBA	PA166122548;PA166115367;PA166127727	Annotation of EMA Label for velaglucerase alfa and GBA;Annotation of FDA Label for velaglucerase alfa and GBA;Annotation of HCSC Label for velaglucerase alfa and GBA
PA28707	GLA	PA166183209;PA166182886	Annotation of EMA Label for migalastat and GLA;Annotation of FDA Label for migalastat and GLA
PA29202	HBB	PA166278461;PA166272141;PA166190023;PA166189821	Annotation of EMA Label for crizanlizumab-tmca and HBB, SELP;Annotation of EMA Label for voxelotor and HBB;Annotation of FDA Label for luspatercept-aamt and HBB;Annotation of FDA Label for voxelotor and HBB
PA35055	HLA-A	PA166273501;PA166277781;PA166151882;PA166182719;PA166277761;PA166127645;PA166224081;PA166277801;PA166123532;PA166184115	Annotation of EMA Label for ipilimumab and CTLA4, HLA-A;Annotation of EMA Label for tebentafusp and HLA-A;Annotation of FDA Label for carbamazepine and HLA-A;Annotation of FDA Label for ipilimumab and HLA-A;Annotation of FDA Label for tebentafusp and HLA-A;Annotation of HCSC Label for carbamazepine and HLA-A, HLA-B;Annotation of HCSC Label for oxcarbazepine and HLA-A;Annotation of HCSC Label for tebentafusp and HLA-A;Annotation of PMDA Label for carbamazepine and HLA-A, HLA-B;Annotation of Swissmedic Label for carbamazepine and HLA-A
PA35056	HLA-B	PA166104896;PA166121326;PA166104833;PA166234701;PA166251522;PA166104780;PA166182766;PA166105213;PA166105058;PA166104860;PA166127627;PA166286161;PA166127645;PA166284241;PA166224061;PA166127701;PA166123553;PA166160668;PA166123532;PA166183563;PA166183783;PA166184116;PA166184506;PA166184448;PA166184502;PA166184173;PA166184268;PA166184345;PA166184504	Annotation of EMA Label for abacavir and HLA-B;Annotation of EMA Label for pazopanib and HLA-B;Annotation of FDA Label for abacavir and HLA-B;Annotation of FDA Label for allopurinol and HLA-B;Annotation of FDA Label for cabotegravir / rilpivirine and HLA-B;Annotation of FDA Label for carbamazepine and HLA-B;Annotation of FDA Label for fosphenytoin and CYP2C19, CYP2C9, HLA-B;Annotation of FDA Label for oxcarbazepine and HLA-B;Annotation of FDA Label for pazopanib and HLA-B, UGT1A1;Annotation of FDA Label for phenytoin and CYP2C19, CYP2C9, HLA-B;Annotation of HCSC Label for abacavir and HLA-B;Annotation of HCSC Label for allopurinol and HLA-B;Annotation of HCSC Label for carbamazepine and HLA-A, HLA-B;Annotation of HCSC Label for fosphenytoin and HLA-B;Annotation of HCSC Label for oxcarbazepine and HLA-B;Annotation of HCSC Label for phenytoin and HLA-B;Annotation of PMDA Label for abacavir and HLA-B;Annotation of PMDA Label for allopurinol and HLA-B;Annotation of PMDA Label for carbamazepine and HLA-A, HLA-B;Annotation of Swissmedic Label for abacavir and HLA-B;Annotation of Swissmedic Label for allopurinol and HLA-B;Annotation of Swissmedic Label for carbamazepine and HLA-B;Annotation of Swissmedic Label for dolutegravir / abacavir / lamivudine and HLA-B;Annotation of Swissmedic Label for flucloxacillin and HLA-B;Annotation of Swissmedic Label for lamivudine / abacavir and HLA-B;Annotation of Swissmedic Label for oxcarbazepine and HLA-B;Annotation of Swissmedic Label for pazopanib and HLA-B;Annotation of Swissmedic Label for phenytoin and CYP2C9, HLA-B;Annotation of Swissmedic Label for zidovudine / lamivudine / abacavir and HLA-B
PA35066	HLA-DQA1	PA166183172;PA166151878;PA166127685;PA166123544;PA166184383	Annotation of EMA Label for lapatinib and HLA-DQA1, HLA-DRB1;Annotation of FDA Label for lapatinib and HLA-DQA1, HLA-DRB1;Annotation of HCSC Label for lapatinib and ERBB2, HLA-DQA1, HLA-DRB1;Annotation of PMDA Label for lapatinib and ERBB2, HLA-DQA1, HLA-DRB1;Annotation of Swissmedic Label for lapatinib and HLA-DQA1, HLA-DRB1
PA35072	HLA-DRB1	PA166183172;PA166151878;PA166127685;PA166123544;PA166184383	Annotation of EMA Label for lapatinib and HLA-DQA1, HLA-DRB1;Annotation of FDA Label for lapatinib and HLA-DQA1, HLA-DRB1;Annotation of HCSC Label for lapatinib and ERBB2, HLA-DQA1, HLA-DRB1;Annotation of PMDA Label for lapatinib and ERBB2, HLA-DQA1, HLA-DRB1;Annotation of Swissmedic Label for lapatinib and HLA-DQA1, HLA-DRB1
PA29317	HMBS	PA166283781;PA166190701;PA166283802	Annotation of EMA Label for givosiran and CPOX, HMBS, PPOX;Annotation of FDA Label for givosiran and CPOX, HMBS, PPOX;Annotation of HCSC Label for givosiran and CPOX, HMBS, PPOX
PA29427	HPRT1	PA166104877;PA166127692;PA166123546	Annotation of FDA Label for mycophenolic acid and HPRT1;Annotation of HCSC Label for mycophenolic acid and HPRT1;Annotation of PMDA Label for mycophenolic acid and HPRT1
PA29444	HRAS	PA166284541;PA166170930;PA166224341;PA166170938;PA166170957;PA166284561	Annotation of EMA Label for encorafenib and HRAS, KRAS, NRAS;Annotation of FDA Label for dabrafenib and HRAS, KRAS, NRAS;Annotation of FDA Label for encorafenib and HRAS, KRAS, NRAS;Annotation of FDA Label for trametinib and HRAS, KRAS, NRAS;Annotation of FDA Label for vemurafenib and HRAS, KRAS, NRAS;Annotation of HCSC Label for encorafenib and HRAS, KRAS, NRAS
PA29487	HSD3B2	PA166160056	Annotation of FDA Label for cholic acid and AKR1D1, AMACR, CYP27A1, CYP7A1, DHCR7, HSD3B2
PA134940289	HSD3B7	PA166182940	Annotation of EMA Label for cholic acid and AKR1D1, HSD3B7
PA29630	IDH1	PA166272161;PA166182727;PA166293921;PA166163420;PA166272261	Annotation of EMA Label for venetoclax and FLT3, IDH1, IDH2, NPM1, TP53;Annotation of FDA Label for ivosidenib and IDH1;Annotation of FDA Label for olutasidenib and IDH1;Annotation of FDA Label for venetoclax and FLT3, IDH1, IDH2, NPM1, TP53;Annotation of HCSC Label for venetoclax and FLT3, IDH1, IDH2, NPM1, TP53
PA29631	IDH2	PA166272161;PA166177486;PA166163420;PA166272261	Annotation of EMA Label for venetoclax and FLT3, IDH1, IDH2, NPM1, TP53;Annotation of FDA Label for enasidenib and IDH2;Annotation of FDA Label for venetoclax and FLT3, IDH1, IDH2, NPM1, TP53;Annotation of HCSC Label for venetoclax and FLT3, IDH1, IDH2, NPM1, TP53
PA29670	IFNAR1	PA166277701;PA166277681;PA166277721	Annotation of EMA Label for anifrolumab and IFNAR1;Annotation of FDA Label for anifrolumab and IFNAR1;Annotation of HCSC Label for anifrolumab and IFNAR1
PA134952671	IFNL3	PA166104872;PA166114378;PA166104855;PA166163421;PA166160005;PA166163439;PA166163428;PA166163412;PA166104801;PA166122592;PA166177518;PA166163417;PA166122594;PA166104867;PA166127640;PA166127710;PA166184129;PA166184132;PA166184158;PA166184434	Annotation of EMA Label for boceprevir and IFNL3;Annotation of EMA Label for telaprevir and IFNL3;Annotation of FDA Label for boceprevir and IFNL3;Annotation of FDA Label for daclatasvir and IFNL3;Annotation of FDA Label for dasabuvir / ombitasvir / paritaprevir / ritonavir and IFNL3;Annotation of FDA Label for elbasvir / grazoprevir and IFNL3;Annotation of FDA Label for ledipasvir / sofosbuvir and IFNL3;Annotation of FDA Label for ombitasvir / paritaprevir / ritonavir and IFNL3;Annotation of FDA Label for peginterferon alfa-2b and IFNL3;Annotation of FDA Label for simeprevir and IFNL3;Annotation of FDA Label for sofosbuvir / velpatasvir / voxilaprevir and IFNL3;Annotation of FDA Label for sofosbuvir / velpatasvir and IFNL3;Annotation of FDA Label for sofosbuvir and IFNL3;Annotation of FDA Label for telaprevir and IFNL3;Annotation of HCSC Label for boceprevir and IFNL3;Annotation of HCSC Label for simeprevir and IFNL3;Annotation of Swissmedic Label for daclatasvir and IFNL3;Annotation of Swissmedic Label for dasabuvir and IFNL3;Annotation of Swissmedic Label for ombitasvir / paritaprevir / ritonavir and IFNL3, IFNL4;Annotation of Swissmedic Label for sofosbuvir and IFNL3, IFNL4
PA166049147	IFNL4	PA166184158;PA166184434	Annotation of Swissmedic Label for ombitasvir / paritaprevir / ritonavir and IFNL3, IFNL4;Annotation of Swissmedic Label for sofosbuvir and IFNL3, IFNL4
PA29784	IL12A	PA166163414	Annotation of FDA Label for ustekinumab and IL12A, IL12B, IL23A
PA29785	IL12B	PA166163414	Annotation of FDA Label for ustekinumab and IL12A, IL12B, IL23A
PA29816	IL1RN	PA166248801	Annotation of FDA Label for anakinra and IL1RN
PA29824	IL23A	PA166163414	Annotation of FDA Label for ustekinumab and IL12A, IL12B, IL23A
PA29828	IL2RA	PA166104883	Annotation of FDA Label for denileukin diftitox and IL2RA
PA29835	IL6R	PA166236241	Annotation of FDA Label for satralizumab and AQP4, IL6R
PA29923	IRS4	PA166293701	Annotation of FDA Label for levothyroxine and IRS4, NKX2-5, PAX8, TBL1X, TSHB
PA29986	JAG1	PA166269301	Annotation of FDA Label for maralixibat and JAG1
PA29989	JAK2	PA166272741;PA166268923	Annotation of EMA Label for ropeginterferon alfa-2b and JAK2;Annotation of FDA Label for ropeginterferon alfa-2b and JAK2
PA30128	KIT	PA166104926;PA166104790;PA166170931;PA166127682	Annotation of EMA Label for imatinib and ABL1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB;Annotation of FDA Label for imatinib and ABL1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB;Annotation of FDA Label for midostaurin and KIT, NPM1;Annotation of HCSC Label for imatinib and ABI1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB
PA30196	KRAS	PA166278202;PA166104908;PA166284541;PA166105319;PA166227161;PA166122488;PA166272601;PA166272681;PA166293262;PA166278181;PA166104826;PA166170930;PA166224341;PA166104809;PA166184561;PA166114944;PA166246485;PA166184636;PA166170938;PA166170957;PA166127648;PA166284561;PA166127699;PA166284701;PA166272581;PA166272321;PA166160274;PA166123547	Annotation of EMA Label for azacitidine and KRAS, NRAS, PTPN11;Annotation of EMA Label for cetuximab and EGFR, KRAS, NRAS;Annotation of EMA Label for encorafenib and HRAS, KRAS, NRAS;Annotation of EMA Label for panitumumab and KRAS, NRAS;Annotation of EMA Label for ramucirumab and KRAS;Annotation of EMA Label for regorafenib and KRAS;Annotation of EMA Label for sotorasib and KRAS;Annotation of EMA Label for tipiracil / trifluridine and ERBB2, KRAS;Annotation of FDA Label for adagrasib and KRAS;Annotation of FDA Label for azacitidine and CBL, KRAS, NRAS, PTPN11;Annotation of FDA Label for cetuximab and EGFR, KRAS, NRAS;Annotation of FDA Label for dabrafenib and HRAS, KRAS, NRAS;Annotation of FDA Label for encorafenib and HRAS, KRAS, NRAS;Annotation of FDA Label for panitumumab and EGFR, KRAS, NRAS;Annotation of FDA Label for ramucirumab and KRAS;Annotation of FDA Label for regorafenib and EGFR, KRAS, VEGFA;Annotation of FDA Label for sotorasib and KRAS;Annotation of FDA Label for tipiracil / trifluridine and ERBB2, KRAS;Annotation of FDA Label for trametinib and HRAS, KRAS, NRAS;Annotation of FDA Label for vemurafenib and HRAS, KRAS, NRAS;Annotation of HCSC Label for cetuximab and EGFR, KRAS;Annotation of HCSC Label for encorafenib and HRAS, KRAS, NRAS;Annotation of HCSC Label for panitumumab and EGFR, KRAS;Annotation of HCSC Label for regorafenib and EGFR, KRAS, VEGFA;Annotation of HCSC Label for sotorasib and KRAS;Annotation of HCSC Label for tipiracil / trifluridine and ERBB2, KRAS;Annotation of PMDA Label for cetuximab and EGFR, KRAS;Annotation of PMDA Label for panitumumab and KRAS
PA30265	LAG3	PA166278121	Annotation of FDA Label for nivolumab / relatlimab and BRAF, CD274, LAG3
PA227	LDLR	PA166283981;PA166294381;PA166273581;PA166121250;PA166159962;PA166104775;PA166251821;PA166160039;PA166273561;PA166114923;PA166114928;PA166114941;PA166127634;PA166283901;PA166127688;PA166127709;PA166123529	Annotation of EMA Label for evinacumab and ANGPTL3, LDLR;Annotation of EMA Label for evolocumab and LDLR, PCSK9;Annotation of EMA Label for inclisiran and APOB, LDLR, PCSK9;Annotation of EMA Label for lomitapide and APOB, LDLR, PCSK9;Annotation of FDA Label for alirocumab and LDLR;Annotation of FDA Label for atorvastatin and LDLR;Annotation of FDA Label for evinacumab and LDLR;Annotation of FDA Label for evolocumab and LDLR, PCSK9;Annotation of FDA Label for inclisiran and APOB, LDLR, PCSK9;Annotation of FDA Label for lomitapide and APOB, LDLR, PCSK9;Annotation of FDA Label for mipomersen and LDLR;Annotation of FDA Label for pravastatin and LDLR;Annotation of HCSC Label for atorvastatin and LDLR;Annotation of HCSC Label for inclisiran and APOB, LDLR, PCSK9;Annotation of HCSC Label for lomitapide and LDLR;Annotation of HCSC Label for rosuvastatin and LDLR;Annotation of PMDA Label for atorvastatin and LDLR
PA228	LEP	PA166273381;PA166235921	Annotation of EMA Label for metreleptin and AGPAT2, BSCL2, LEP, LMNB2;Annotation of FDA Label for metreleptin and LEP
PA229	LEPR	PA166272801;PA166235941	Annotation of EMA Label for setmelanotide and LEPR, PCSK1, POMC;Annotation of FDA Label for setmelanotide and LEPR, PCSK1, POMC
PA231	LMNA	PA166235601	Annotation of FDA Label for lonafarnib and LMNA, ZMPSTE24
PA30404	LMNB2	PA166273381	Annotation of EMA Label for metreleptin and AGPAT2, BSCL2, LEP, LMNB2
PA30763	MET	PA166272641;PA166224202;PA166252881;PA166271361;PA166272341	Annotation of EMA Label for tepotinib and MET;Annotation of FDA Label for capmatinib and MET;Annotation of FDA Label for tepotinib and MET;Annotation of HCSC Label for capmatinib and MET;Annotation of HCSC Label for tepotinib and MET
PA30825	MKI67	PA166177475	Annotation of FDA Label for abemaciclib and ERBB2, ESR1, ESR2, MKI67, PGR
PA164723053	MMADHC	PA166293941;PA166293301;PA166293961	Annotation of EMA Label for betaine and CBS, MMADHC, MTHFR;Annotation of FDA Label for betaine and CBS, MMADHC, MTHFR;Annotation of HCSC Label for betaine and CBS, MMADHC, MTHFR
PA30900	MOCS1	PA166283961;PA166252781	Annotation of EMA Label for fosdenopterin and MOCS1;Annotation of FDA Label for fosdenopterin and MOCS1
PA31111	MS4A1	PA166121246;PA166121252;PA166122546;PA166122589;PA166114921;PA166105059;PA166105240;PA166159584	Annotation of EMA Label for ibritumomab and MS4A1;Annotation of EMA Label for ofatumumab and MS4A1;Annotation of EMA Label for rituximab and MS4A1;Annotation of FDA Label for afutuzumab and MS4A1;Annotation of FDA Label for ibritumomab and MS4A1;Annotation of FDA Label for ofatumumab and MS4A1;Annotation of FDA Label for rituximab and MS4A1;Annotation of HCSC Label for afutuzumab and MS4A1
PA245	MTHFR	PA166293941;PA166293301;PA166293961;PA166127695	Annotation of EMA Label for betaine and CBS, MMADHC, MTHFR;Annotation of FDA Label for betaine and CBS, MMADHC, MTHFR;Annotation of HCSC Label for betaine and CBS, MMADHC, MTHFR;Annotation of HCSC Label for ethinyl estradiol / norelgestromin and F2, F5, MTHFR, PROC, PROS1, SERPINC1
PA31359	MYCN	PA166160061	Annotation of FDA Label for dinutuximab and MYCN
PA31361	MYD88	PA166272123;PA166224441;PA166268961;PA166273081	Annotation of EMA Label for zanubrutinib and MYD88;Annotation of FDA Label for ibrutinib and MYD88;Annotation of FDA Label for zanubrutinib and MYD88;Annotation of HCSC Label for zanubrutinib and MYD88
PA134968729	NAGS	PA166119825;PA166114908;PA166269081;PA166104794;PA166129525	Annotation of EMA Label for carglumic acid and NAGS;Annotation of FDA Label for carglumic acid and NAGS;Annotation of FDA Label for glycerol phenylbutyrate and NAGS;Annotation of FDA Label for sodium benzoate / sodium phenylacetate and ARG1, ASL, ASS1, CPS1, NAGS, OTC;Annotation of HCSC Label for carglumic acid and NAGS
PA18	NAT2	PA166182925;PA166227221;PA166185151;PA166182021;PA166104828;PA166104850;PA166184754;PA166104874;PA166104892;PA166229921;PA166227321;PA166161087;PA166183784	Annotation of EMA Label for amifampridine phosphate and NAT2;Annotation of EMA Label for amifampridine phosphate and NAT2;Annotation of FDA Label for amifampridine and NAT2;Annotation of FDA Label for amifampridine phosphate and NAT2;Annotation of FDA Label for hydralazine / isosorbide dinitrate and NAT2;Annotation of FDA Label for isoniazid / pyrazinamide / rifampin and NAT2;Annotation of FDA Label for procainamide and NAT2;Annotation of FDA Label for sulfamethoxazole / trimethoprim and G6PD, NAT2;Annotation of FDA Label for sulfasalazine and G6PD, NAT2;Annotation of HCSC Label for amifampridine and NAT2;Annotation of HCSC Label for amifampridine phosphate and NAT2;Annotation of PMDA Label for isoniazid and NAT2;Annotation of Swissmedic Label for amifampridine phosphate and NAT2
PA134991624	NECTIN4	PA166284001;PA166190141;PA166284021	Annotation of EMA Label for enfortumab vedotin and NECTIN4;Annotation of FDA Label for enfortumab vedotin and NECTIN4;Annotation of HCSC Label for enfortumab vedotin and NECTIN4
PA24202	NKX2-5	PA166293701	Annotation of FDA Label for levothyroxine and IRS4, NKX2-5, PAX8, TBL1X, TSHB
PA26512	NLRP3	PA166235261	Annotation of FDA Label for anakinra and NLRP3
PA31712	NPM1	PA166272161;PA166170931;PA166163420;PA166272261	Annotation of EMA Label for venetoclax and FLT3, IDH1, IDH2, NPM1, TP53;Annotation of FDA Label for midostaurin and KIT, NPM1;Annotation of FDA Label for venetoclax and FLT3, IDH1, IDH2, NPM1, TP53;Annotation of HCSC Label for venetoclax and FLT3, IDH1, IDH2, NPM1, TP53
PA378	NR1I2	PA166184441	Annotation of Swissmedic Label for dolutegravir and CYP3A4, CYP3A5, NR1I2, UGT1A1
PA31768	NRAS	PA166278202;PA166104908;PA166284541;PA166105319;PA166278181;PA166104826;PA166170930;PA166224341;PA166104809;PA166170938;PA166170957;PA166284561	Annotation of EMA Label for azacitidine and KRAS, NRAS, PTPN11;Annotation of EMA Label for cetuximab and EGFR, KRAS, NRAS;Annotation of EMA Label for encorafenib and HRAS, KRAS, NRAS;Annotation of EMA Label for panitumumab and KRAS, NRAS;Annotation of FDA Label for azacitidine and CBL, KRAS, NRAS, PTPN11;Annotation of FDA Label for cetuximab and EGFR, KRAS, NRAS;Annotation of FDA Label for dabrafenib and HRAS, KRAS, NRAS;Annotation of FDA Label for encorafenib and HRAS, KRAS, NRAS;Annotation of FDA Label for panitumumab and EGFR, KRAS, NRAS;Annotation of FDA Label for trametinib and HRAS, KRAS, NRAS;Annotation of FDA Label for vemurafenib and HRAS, KRAS, NRAS;Annotation of HCSC Label for encorafenib and HRAS, KRAS, NRAS
PA31817	NTRK1	PA166284042;PA166190201;PA166182734;PA166284062	Annotation of EMA Label for entrectinib and NTRK1, NTRK2, NTRK3, ROS1;Annotation of FDA Label for entrectinib and NTRK1, NTRK2, NTRK3, ROS1;Annotation of FDA Label for larotrectinib sulfate and NTRK1, NTRK2, NTRK3;Annotation of HCSC Label for entrectinib and NTRK1, NTRK2, NTRK3, ROS1
PA31818	NTRK2	PA166284042;PA166190201;PA166182734;PA166284062	Annotation of EMA Label for entrectinib and NTRK1, NTRK2, NTRK3, ROS1;Annotation of FDA Label for entrectinib and NTRK1, NTRK2, NTRK3, ROS1;Annotation of FDA Label for larotrectinib sulfate and NTRK1, NTRK2, NTRK3;Annotation of HCSC Label for entrectinib and NTRK1, NTRK2, NTRK3, ROS1
PA31819	NTRK3	PA166284042;PA166190201;PA166182734;PA166284062	Annotation of EMA Label for entrectinib and NTRK1, NTRK2, NTRK3, ROS1;Annotation of FDA Label for entrectinib and NTRK1, NTRK2, NTRK3, ROS1;Annotation of FDA Label for larotrectinib sulfate and NTRK1, NTRK2, NTRK3;Annotation of HCSC Label for entrectinib and NTRK1, NTRK2, NTRK3, ROS1
PA134963132	NUDT15	PA166121251;PA166104782;PA166104810;PA166104838;PA166184112;PA166183781	Annotation of EMA Label for mercaptopurine and NUDT15, TPMT;Annotation of FDA Label for azathioprine and NUDT15, TPMT;Annotation of FDA Label for mercaptopurine and NUDT15, TPMT;Annotation of FDA Label for thioguanine and NUDT15, TPMT;Annotation of Swissmedic Label for azathioprine and NUDT15, TPMT;Annotation of Swissmedic Label for mercaptopurine and NUDT15, TPMT
PA32840	OTC	PA166269701;PA166114381;PA166269101;PA166104794;PA166114317;PA166104825;PA166283881;PA166127712;PA166127726;PA166123552	Annotation of EMA Label for glycerol phenylbutyrate and ARG1, ASL, ASS1, CPS1, OTC;Annotation of EMA Label for sodium phenylbutyrate and ASS1, CPS1, OTC;Annotation of FDA Label for glycerol phenylbutyrate and ASS1, CPS1, OTC;Annotation of FDA Label for sodium benzoate / sodium phenylacetate and ARG1, ASL, ASS1, CPS1, NAGS, OTC;Annotation of FDA Label for sodium phenylbutyrate and ASS1, CPS1, OTC;Annotation of FDA Label for valproic acid and OTC;Annotation of HCSC Label for glycerol phenylbutyrate and ARG1, ASL, ASS1, CPS1, OTC;Annotation of HCSC Label for sodium phenylbutyrate and ASS1, CPS1, OTC;Annotation of HCSC Label for valproic acid and OTC, POLG;Annotation of PMDA Label for valproic acid and CPS1, OTC
PA32962	PAX8	PA166293701	Annotation of FDA Label for levothyroxine and IRS4, NKX2-5, PAX8, TBL1X, TSHB
PA33089	PCSK1	PA166272801;PA166235941	Annotation of EMA Label for setmelanotide and LEPR, PCSK1, POMC;Annotation of FDA Label for setmelanotide and LEPR, PCSK1, POMC
PA38617	PCSK9	PA166294381;PA166273581;PA166121250;PA166160039;PA166273561;PA166114923;PA166283901	Annotation of EMA Label for evolocumab and LDLR, PCSK9;Annotation of EMA Label for inclisiran and APOB, LDLR, PCSK9;Annotation of EMA Label for lomitapide and APOB, LDLR, PCSK9;Annotation of FDA Label for evolocumab and LDLR, PCSK9;Annotation of FDA Label for inclisiran and APOB, LDLR, PCSK9;Annotation of FDA Label for lomitapide and APOB, LDLR, PCSK9;Annotation of HCSC Label for inclisiran and APOB, LDLR, PCSK9
PA33110	PDCD1	PA166169884	Annotation of FDA Label for durvalumab and ALK, CD274, EGFR, PDCD1
PA33147	PDGFRA	PA166230001;PA166104926;PA166223941;PA166104790;PA166163435;PA166127682	Annotation of EMA Label for avapritinib and PDGFRA;Annotation of EMA Label for imatinib and ABL1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB;Annotation of FDA Label for avapritinib and PDGFRA;Annotation of FDA Label for imatinib and ABL1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB;Annotation of FDA Label for olaratumab and PDGFRA;Annotation of HCSC Label for imatinib and ABI1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB
PA33148	PDGFRB	PA166104926;PA166104790;PA166127682	Annotation of EMA Label for imatinib and ABL1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB;Annotation of FDA Label for imatinib and ABL1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB;Annotation of HCSC Label for imatinib and ABI1, BCR, FIP1L1, KIT, PDGFRA, PDGFRB
PA266	PGR	PA166182923;PA166104919;PA166183220;PA166183247;PA166183421;PA166177475;PA166105070;PA166182760;PA166182725;PA166104923;PA166104792;PA166182758;PA166182724;PA166104791;PA166104797;PA166178724;PA166182890;PA166170933;PA166170048;PA166104819;PA166170939;PA166127630;PA166127687	Annotation of EMA Label for abemaciclib and ERBB2, ESR1, ESR2, PGR;Annotation of EMA Label for fulvestrant and ERBB2, ESR1, ESR2, PGR;Annotation of EMA Label for neratinib and ERBB2, ESR1, ESR2, PGR;Annotation of EMA Label for palbociclib and ERBB2, ESR1, ESR2, PGR;Annotation of EMA Label for ribociclib and ERBB2, ESR1, ESR2, PGR;Annotation of FDA Label for abemaciclib and ERBB2, ESR1, ESR2, MKI67, PGR;Annotation of FDA Label for anastrozole and ESR1, ESR2, PGR;Annotation of FDA Label for docetaxel and ESR1, ESR2, PGR;Annotation of FDA Label for eribulin and ERBB2, ESR1, ESR2, PGR;Annotation of FDA Label for exemestane and ESR1, ESR2, PGR;Annotation of FDA Label for fulvestrant and ESR1, ESR2, PGR;Annotation of FDA Label for goserelin and ESR1, ESR2, PGR;Annotation of FDA Label for ixabepilone and ERBB2, ESR1, ESR2, PGR;Annotation of FDA Label for lapatinib and ERBB2, ESR1, ESR2, PGR;Annotation of FDA Label for letrozole and ESR1, ESR2, PGR;Annotation of FDA Label for neratinib and ESR1, ESR2, PGR;Annotation of FDA Label for olaparib and ESR1, ESR2, PGR, PPP2R2A;Annotation of FDA Label for pertuzumab and ESR1, ESR2, PGR;Annotation of FDA Label for ribociclib and ERBB2, ESR1, ESR2, PGR;Annotation of FDA Label for tamoxifen and ESR1, ESR2, PGR;Annotation of FDA Label for trastuzumab and ESR1, ESR2, PGR;Annotation of HCSC Label for anastrozole and ESR1, ESR2, PGR;Annotation of HCSC Label for letrozole and ESR1, ESR2, PGR
PA33308	PIK3CA	PA166227181;PA166184524;PA166227201	Annotation of EMA Label for alpelisib and ERBB2, ESR1, ESR2, PIK3CA;Annotation of FDA Label for alpelisib and ERBB2, ESR1, ESR2, PIK3CA;Annotation of HCSC Label for alpelisib and ERBB2, ESR1, ESR2, PIK3CA
PA33352	PKLR	PA166278081	Annotation of FDA Label for mitapivat and PKLR
PA33439	PML	PA166104821;PA166104846;PA166104817;PA166127632;PA166127725;PA166123527;PA166123551	Annotation of EMA Label for arsenic trioxide and PML, RARA;Annotation of FDA Label for arsenic trioxide and PML, RARA;Annotation of FDA Label for tretinoin and PML, RARA;Annotation of HCSC Label for arsenic trioxide and PML, RARA;Annotation of HCSC Label for tretinoin and PML, RARA;Annotation of PMDA Label for arsenic trioxide and PML, RARA;Annotation of PMDA Label for tretinoin and PML, RARA
PA33500	POLG	PA166127663;PA166170958;PA166127665;PA166127726	Annotation of FDA Label for divalproex sodium and POLG;Annotation of FDA Label for valproic acid and POLG;Annotation of HCSC Label for divalproex sodium and POLG;Annotation of HCSC Label for valproic acid and OTC, POLG
PA33526	POMC	PA166272801;PA166235941	Annotation of EMA Label for setmelanotide and LEPR, PCSK1, POMC;Annotation of FDA Label for setmelanotide and LEPR, PCSK1, POMC
PA33608	PPOX	PA166283781;PA166190701;PA166283802	Annotation of EMA Label for givosiran and CPOX, HMBS, PPOX;Annotation of FDA Label for givosiran and CPOX, HMBS, PPOX;Annotation of HCSC Label for givosiran and CPOX, HMBS, PPOX
PA33668	PPP2R2A	PA166182890	Annotation of FDA Label for olaparib and ESR1, ESR2, PGR, PPP2R2A
PA33732	PRF1	PA166182764	Annotation of FDA Label for emapalumab and PRF1, RAB27A, SH2D1A, STX11, STXBP2, UNC13D, XIAP
PA33799	PROC	PA166240301;PA166120287;PA166179855;PA166190261;PA166182749;PA166238981;PA166104776;PA166127666;PA166127695	Annotation of EMA Label for avatrombopag and CYP2C9, F2, F5, PROC, PROS1, SERPINC1;Annotation of EMA Label for ethinyl estradiol / norelgestromin and F5, PROC, PROS1, SERPINC1;Annotation of FDA Label for avatrombopag and F2, F5, PROC, PROS1, SERPINC1;Annotation of FDA Label for estradiol / progesterone and PROC, PROS1, SERPINC1;Annotation of FDA Label for lusutrombopag and F2, F5, PROC, PROS1, SERPINC1;Annotation of FDA Label for synthetic conjugated estrogens, A and PROC, PROS1, SERPINC1;Annotation of FDA Label for warfarin and CYP2C9, PROC, PROS1, VKORC1;Annotation of HCSC Label for drospirenone / ethinyl estradiol and F5, PROC, PROS1, SERPINC1;Annotation of HCSC Label for ethinyl estradiol / norelgestromin and F2, F5, MTHFR, PROC, PROS1, SERPINC1
PA33809	PROS1	PA166240301;PA166120287;PA166179855;PA166190261;PA166182749;PA166238981;PA166104776;PA166127666;PA166127695	Annotation of EMA Label for avatrombopag and CYP2C9, F2, F5, PROC, PROS1, SERPINC1;Annotation of EMA Label for ethinyl estradiol / norelgestromin and F5, PROC, PROS1, SERPINC1;Annotation of FDA Label for avatrombopag and F2, F5, PROC, PROS1, SERPINC1;Annotation of FDA Label for estradiol / progesterone and PROC, PROS1, SERPINC1;Annotation of FDA Label for lusutrombopag and F2, F5, PROC, PROS1, SERPINC1;Annotation of FDA Label for synthetic conjugated estrogens, A and PROC, PROS1, SERPINC1;Annotation of FDA Label for warfarin and CYP2C9, PROC, PROS1, VKORC1;Annotation of HCSC Label for drospirenone / ethinyl estradiol and F5, PROC, PROS1, SERPINC1;Annotation of HCSC Label for ethinyl estradiol / norelgestromin and F2, F5, MTHFR, PROC, PROS1, SERPINC1
PA33986	PTPN11	PA166278202;PA166278181	Annotation of EMA Label for azacitidine and KRAS, NRAS, PTPN11;Annotation of FDA Label for azacitidine and CBL, KRAS, NRAS, PTPN11
PA34117	RAB27A	PA166182764	Annotation of FDA Label for emapalumab and PRF1, RAB27A, SH2D1A, STX11, STXBP2, UNC13D, XIAP
PA34225	RARA	PA166104821;PA166104846;PA166104817;PA166127632;PA166127725;PA166123527;PA166123551	Annotation of EMA Label for arsenic trioxide and PML, RARA;Annotation of FDA Label for arsenic trioxide and PML, RARA;Annotation of FDA Label for tretinoin and PML, RARA;Annotation of HCSC Label for arsenic trioxide and PML, RARA;Annotation of HCSC Label for tretinoin and PML, RARA;Annotation of PMDA Label for arsenic trioxide and PML, RARA;Annotation of PMDA Label for tretinoin and PML, RARA
PA34335	RET	PA166273121;PA166272781;PA166122907;PA166183442;PA166160021;PA166235981;PA166225121;PA166281722;PA166278601	Annotation of EMA Label for pralsetinib and RET;Annotation of EMA Label for selpercatinib and RET;Annotation of EMA Label for vandetanib and RET;Annotation of EMA Label for vandetanib and RET;Annotation of FDA Label for cabozantinib and RET;Annotation of FDA Label for pralsetinib and RET;Annotation of FDA Label for selpercatinib and RET;Annotation of HCSC Label for pralsetinib and RET;Annotation of HCSC Label for selpercatinib and RET
PA34633	ROS1	PA166278421;PA166104909;PA166284042;PA166251421;PA166104859;PA166190201;PA166182747;PA166278442;PA166284062	Annotation of EMA Label for cemiplimab-rwlc and ALK, CD274, EGFR, ROS1;Annotation of EMA Label for crizotinib and ALK, ROS1;Annotation of EMA Label for entrectinib and NTRK1, NTRK2, NTRK3, ROS1;Annotation of FDA Label for cemiplimab-rwlc and ALK, CD274, EGFR, ROS1;Annotation of FDA Label for crizotinib and ALK, ROS1;Annotation of FDA Label for entrectinib and NTRK1, NTRK2, NTRK3, ROS1;Annotation of FDA Label for lorlatinib and ROS1;Annotation of HCSC Label for cemiplimab-rwlc and ALK, CD274, EGFR, ROS1;Annotation of HCSC Label for entrectinib and NTRK1, NTRK2, NTRK3, ROS1
PA34896	RYR1	PA166129515;PA166169912;PA166129517;PA166129519;PA166122970;PA166129516;PA166129518;PA166129520	Annotation of FDA Label for desflurane and CACNA1S, RYR1;Annotation of FDA Label for enflurane and CACNA1S, RYR1;Annotation of FDA Label for isoflurane and CACNA1S, RYR1;Annotation of FDA Label for sevoflurane and CACNA1S, RYR1;Annotation of FDA Label for succinylcholine and BCHE, CACNA1S, RYR1;Annotation of HCSC Label for desflurane and CACNA1S, RYR1;Annotation of HCSC Label for isoflurane and CACNA1S, RYR1;Annotation of HCSC Label for sevoflurane and CACNA1S, RYR1
PA35643	SELP	PA166278461	Annotation of EMA Label for crizanlizumab-tmca and HBB, SELP
PA35026	SERPINC1	PA166240301;PA166104907;PA166120287;PA166179855;PA166104912;PA166190261;PA166182749;PA166238981;PA166127666;PA166127668;PA166127695;PA166123538	Annotation of EMA Label for avatrombopag and CYP2C9, F2, F5, PROC, PROS1, SERPINC1;Annotation of EMA Label for eltrombopag and F5, SERPINC1;Annotation of EMA Label for ethinyl estradiol / norelgestromin and F5, PROC, PROS1, SERPINC1;Annotation of FDA Label for avatrombopag and F2, F5, PROC, PROS1, SERPINC1;Annotation of FDA Label for eltrombopag and F5, SERPINC1;Annotation of FDA Label for estradiol / progesterone and PROC, PROS1, SERPINC1;Annotation of FDA Label for lusutrombopag and F2, F5, PROC, PROS1, SERPINC1;Annotation of FDA Label for synthetic conjugated estrogens, A and PROC, PROS1, SERPINC1;Annotation of HCSC Label for drospirenone / ethinyl estradiol and F5, PROC, PROS1, SERPINC1;Annotation of HCSC Label for eltrombopag and F5, SERPINC1;Annotation of HCSC Label for ethinyl estradiol / norelgestromin and F2, F5, MTHFR, PROC, PROS1, SERPINC1;Annotation of PMDA Label for eltrombopag and SERPINC1
PA35728	SH2D1A	PA166182764	Annotation of FDA Label for emapalumab and PRF1, RAB27A, SH2D1A, STX11, STXBP2, UNC13D, XIAP
PA35758	SI	PA166277841	Annotation of FDA Label for sacrosidase and SI
PA331	SLC22A2	PA166123390	Annotation of EMA Label for fampridine and SLC22A2
PA134865839	SLCO1B1	PA166234723;PA166182762;PA166105023;PA166234761;PA166251621;PA166183786;PA166184427;PA166184429;PA166184430;PA166184386;PA166184393;PA166184499;PA166184500	Annotation of FDA Label for atorvastatin and SLCO1B1;Annotation of FDA Label for elagolix and SLCO1B1;Annotation of FDA Label for rosuvastatin and SLCO1B1;Annotation of FDA Label for simvastatin and SLCO1B1;Annotation of FDA Label for viloxazine and SLCO1B1;Annotation of Swissmedic Label for amlodipine / atorvastatin / perindopril arginine and G6PD, SLCO1B1;Annotation of Swissmedic Label for ezetimibe / rosuvastatin and ABCG2, SLCO1B1;Annotation of Swissmedic Label for ezetimibe / simvastatin and SLCO1B1;Annotation of Swissmedic Label for fenofibrate, simvastatin and SLCO1B1;Annotation of Swissmedic Label for letermovir and SLCO1B1, UGT1A1;Annotation of Swissmedic Label for pitavastatin and SLCO1B1;Annotation of Swissmedic Label for rosuvastatin and ABCG2, SLCO1B1;Annotation of Swissmedic Label for simvastatin and SLCO1B1
PA35966	SMN1	PA166272721;PA166236221;PA166278701	Annotation of EMA Label for risdiplam and SMN1, SMN2;Annotation of FDA Label for risdiplam and SMN1, SMN2;Annotation of HCSC Label for risdiplam and SMN1, SMN2
PA35967	SMN2	PA166273281;PA166272721;PA166185180;PA166236221;PA166282861;PA166278701	Annotation of EMA Label for nusinersen and SMN2;Annotation of EMA Label for risdiplam and SMN1, SMN2;Annotation of FDA Label for nusinersen and SMN2;Annotation of FDA Label for risdiplam and SMN1, SMN2;Annotation of HCSC Label for nusinersen and SMN2;Annotation of HCSC Label for risdiplam and SMN1, SMN2
PA36154	SSTR1	PA166273423;PA166225001;PA166278481	Annotation of EMA Label for lutetium (177Lu) oxodotreotide and SSTR1, SSTR2, SSTR3, SSTR4, SSTR5;Annotation of FDA Label for lutetium (177Lu) oxodotreotide and SSTR1, SSTR2, SSTR3, SSTR4, SSTR5;Annotation of HCSC Label for lutetium (177Lu) oxodotreotide and SSTR1, SSTR2, SSTR3, SSTR4, SSTR5
PA36155	SSTR2	PA166273423;PA166225001;PA166278481	Annotation of EMA Label for lutetium (177Lu) oxodotreotide and SSTR1, SSTR2, SSTR3, SSTR4, SSTR5;Annotation of FDA Label for lutetium (177Lu) oxodotreotide and SSTR1, SSTR2, SSTR3, SSTR4, SSTR5;Annotation of HCSC Label for lutetium (177Lu) oxodotreotide and SSTR1, SSTR2, SSTR3, SSTR4, SSTR5
PA36156	SSTR3	PA166273423;PA166225001;PA166278481	Annotation of EMA Label for lutetium (177Lu) oxodotreotide and SSTR1, SSTR2, SSTR3, SSTR4, SSTR5;Annotation of FDA Label for lutetium (177Lu) oxodotreotide and SSTR1, SSTR2, SSTR3, SSTR4, SSTR5;Annotation of HCSC Label for lutetium (177Lu) oxodotreotide and SSTR1, SSTR2, SSTR3, SSTR4, SSTR5
PA36157	SSTR4	PA166273423;PA166225001;PA166278481	Annotation of EMA Label for lutetium (177Lu) oxodotreotide and SSTR1, SSTR2, SSTR3, SSTR4, SSTR5;Annotation of FDA Label for lutetium (177Lu) oxodotreotide and SSTR1, SSTR2, SSTR3, SSTR4, SSTR5;Annotation of HCSC Label for lutetium (177Lu) oxodotreotide and SSTR1, SSTR2, SSTR3, SSTR4, SSTR5
PA36158	SSTR5	PA166273423;PA166225001;PA166278481	Annotation of EMA Label for lutetium (177Lu) oxodotreotide and SSTR1, SSTR2, SSTR3, SSTR4, SSTR5;Annotation of FDA Label for lutetium (177Lu) oxodotreotide and SSTR1, SSTR2, SSTR3, SSTR4, SSTR5;Annotation of HCSC Label for lutetium (177Lu) oxodotreotide and SSTR1, SSTR2, SSTR3, SSTR4, SSTR5
PA36229	STX11	PA166182764	Annotation of FDA Label for emapalumab and PRF1, RAB27A, SH2D1A, STX11, STXBP2, UNC13D, XIAP
PA36242	STXBP2	PA166182764	Annotation of FDA Label for emapalumab and PRF1, RAB27A, SH2D1A, STX11, STXBP2, UNC13D, XIAP
PA36349	TBL1X	PA166293701	Annotation of FDA Label for levothyroxine and IRS4, NKX2-5, PAX8, TBL1X, TSHB
PA36616	TNFRSF8	PA166104904;PA166185145;PA166160288	Annotation of EMA Label for brentuximab vedotin and TNFRSF8;Annotation of FDA Label for brentuximab vedotin and TNFRSF8;Annotation of HCSC Label for brentuximab vedotin and TNFRSF8
PA434	TNFSF13B	PA166119824;PA166114905;PA166159938	Annotation of EMA Label for belimumab and TNFSF13B;Annotation of FDA Label for belimumab and TNFSF13B;Annotation of HCSC Label for belimumab and TNFSF13B
PA36679	TP53	PA166272161;PA166163420;PA166272261	Annotation of EMA Label for venetoclax and FLT3, IDH1, IDH2, NPM1, TP53;Annotation of FDA Label for venetoclax and FLT3, IDH1, IDH2, NPM1, TP53;Annotation of HCSC Label for venetoclax and FLT3, IDH1, IDH2, NPM1, TP53
PA356	TPMT	PA166121251;PA166104782;PA166104853;PA166104810;PA166104838;PA166127635;PA166127690;PA166127720;PA166123530;PA166184112;PA166183781;PA166184424	Annotation of EMA Label for mercaptopurine and NUDT15, TPMT;Annotation of FDA Label for azathioprine and NUDT15, TPMT;Annotation of FDA Label for cisplatin and TPMT;Annotation of FDA Label for mercaptopurine and NUDT15, TPMT;Annotation of FDA Label for thioguanine and NUDT15, TPMT;Annotation of HCSC Label for azathioprine and TPMT;Annotation of HCSC Label for mercaptopurine and TPMT;Annotation of HCSC Label for thioguanine and TPMT;Annotation of PMDA Label for azathioprine and TPMT;Annotation of Swissmedic Label for azathioprine and NUDT15, TPMT;Annotation of Swissmedic Label for mercaptopurine and NUDT15, TPMT;Annotation of Swissmedic Label for thioguanine and TPMT
PA26600	TPP1	PA166182934;PA166169880	Annotation of EMA Label for cerliponase alfa and TPP1;Annotation of FDA Label for cerliponase alfa and TPP1
PA37041	TSHB	PA166293701	Annotation of FDA Label for levothyroxine and IRS4, NKX2-5, PAX8, TBL1X, TSHB
PA37069	TTR	PA166272621;PA166182757;PA166184565;PA166277661;PA166272361	Annotation of EMA Label for tafamidis and TTR;Annotation of FDA Label for inotersen and TTR;Annotation of FDA Label for tafamidis and TTR;Annotation of FDA Label for vutrisiran and TTR;Annotation of HCSC Label for tafamidis and TTR
PA359	TYMS	PA166184451	Annotation of Swissmedic Label for fluorouracil and TYMS
PA420	UGT1A1	PA166123387;PA166182929;PA166182943;PA166182949;PA166182952;PA166183251;PA166271541;PA166127662;PA166129553;PA166179871;PA166251501;PA166160010;PA166104800;PA166104831;PA166151853;PA166105058;PA166179887;PA166225101;PA166284761;PA166127683;PA166151974;PA166271561;PA166123543;PA166123526;PA166184441;PA166184377;PA166184378;PA166184386	Annotation of EMA Label for axitinib and CYP2C19, UGT1A1;Annotation of EMA Label for binimetinib and UGT1A1;Annotation of EMA Label for dolutegravir and UGT1A1;Annotation of EMA Label for erlotinib and UGT1A1;Annotation of EMA Label for irinotecan and UGT1A1;Annotation of EMA Label for raltegravir and UGT1A1;Annotation of EMA Label for sacituzumab govitecan-hziy and UGT1A1;Annotation of FDA Label for arformoterol and CYP2D6, UGT1A1;Annotation of FDA Label for belinostat and UGT1A1;Annotation of FDA Label for binimetinib and UGT1A1;Annotation of FDA Label for cabotegravir / rilpivirine and UGT1A1;Annotation of FDA Label for dolutegravir and UGT1A1;Annotation of FDA Label for indacaterol and UGT1A1;Annotation of FDA Label for irinotecan and UGT1A1;Annotation of FDA Label for nilotinib and UGT1A1;Annotation of FDA Label for pazopanib and HLA-B, UGT1A1;Annotation of FDA Label for raltegravir and UGT1A1;Annotation of FDA Label for sacituzumab govitecan-hziy and UGT1A1;Annotation of HCSC Label for cabotegravir / rilpivirine and UGT1A1;Annotation of HCSC Label for irinotecan and UGT1A1;Annotation of HCSC Label for nilotinib and UGT1A1;Annotation of HCSC Label for sacituzumab govitecan-hziy and UGT1A1;Annotation of PMDA Label for indacaterol and UGT1A1;Annotation of PMDA Label for irinotecan and UGT1A1;Annotation of Swissmedic Label for dolutegravir and CYP3A4, CYP3A5, NR1I2, UGT1A1;Annotation of Swissmedic Label for indacaterol and UGT1A1;Annotation of Swissmedic Label for irinotecan and UGT1A1;Annotation of Swissmedic Label for letermovir and SLCO1B1, UGT1A1
PA37189	UGT2B17	PA166268882;PA166278001	Annotation of FDA Label for belzutifan and CYP2C19, UGT2B17;Annotation of HCSC Label for belzutifan and CYP2C19, UGT2B17
PA134919958	UNC13D	PA166182764	Annotation of FDA Label for emapalumab and PRF1, RAB27A, SH2D1A, STX11, STXBP2, UNC13D, XIAP
PA37302	VEGFA	PA166114944;PA166284701	Annotation of FDA Label for regorafenib and EGFR, KRAS, VEGFA;Annotation of HCSC Label for regorafenib and EGFR, KRAS, VEGFA
PA37307	VHL	PA166268881;PA166277981	Annotation of FDA Label for belzutifan and VHL;Annotation of HCSC Label for belzutifan and VHL
PA133787052	VKORC1	PA166104776;PA166127732	Annotation of FDA Label for warfarin and CYP2C9, PROC, PROS1, VKORC1;Annotation of HCSC Label for warfarin and CYP2C9, VKORC1
PA25361	XIAP	PA166182764	Annotation of FDA Label for emapalumab and PRF1, RAB27A, SH2D1A, STX11, STXBP2, UNC13D, XIAP
PA37466	ZMPSTE24	PA166235601	Annotation of FDA Label for lonafarnib and LMNA, ZMPSTE24
